Section 12

EurekaMag PDF full texts Chapter 11,160


Bonilla-Jaime, H.; Retana-Márquez, S.; Vazquez-Palacios, G.; Velázquez-Moctezuma, J. 2003: Plasma levels of corticosterone and testosterone after sexual activity in male rats treated neonatally with clomipramine. Behavioural Pharmacology 14(4): 357-362
Nielsen, N.E.; Ahlner, J.; Malmstedt, J.; Ohman, K.P.; Swahn, E. 1999: Plasma levels of cyclic GMP and endothelin in postmenopausal women with unstable coronary artery disease. Scandinavian Journal of Clinical and Laboratory Investigation 59(5): 325-334
Haack, M.; Hinze-Selch, D.; Fenzel, T.; Kraus, T.; Kühn, M.; Schuld, A.; Pollmächer, T. 1999: Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. Journal of Psychiatric Research 33(5): 407-418
Kitzlerová, E.; Slavícek, J.; Pisvejcová, K.; Anders, M.; Dohnalová, A.; Balíková, M. 2003: Plasma levels of dosulepine and heart electric field. Physiological Research 52(3): 319-325
Brunner-La Rocca, H.P.; Weilenmann, D.; Kiowski, W.; Maly, F.E.; Follath, F. 1999: Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events. Journal of Pharmacology and Experimental Therapeutics 289(1): 565-571
Stearns-Kurosawa, D.J.; Swindle, K.; D'Angelo, A.; Della Valle, P.; Fattorini, A.; Caron, N.; Grimaux, M.; Woodhams, B.; Kurosawa, S. 2002: Plasma levels of endothelial protein C receptor respond to anticoagulant treatment. Blood 99(2): 526-530
Migdalis, I.N.; Kalogeropoulou, K.; Iliopoulou, V.; Triantafilou, P.; Charalabides, J.; Mortzos, G.; Cordopatis, C. 2001: Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy. Diabetes Research and Clinical Practice 54(2): 129-136
Letizia, C.; Boirivant, M.; De Toma, G.; Cerci, S.; Subioli, S.; Scuro, L.; Ferrari, P.; Pallone, F. 1998: Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis. Italian Journal of Gastroenterology and Hepatology 30(3): 266-269
Cellini, M.; Santiago, L.; Versura, P.; Caramazza, R. 2002: Plasma levels of endothelin-1 in retinitis pigmentosa. Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 216(4): 265-268
Letizia, C.; Danese, A.; Reale, M.G.; Caliumi, C.; Delfini, E.; Subioli, S.; Cerci, S.; D'Erasmo, E. 2001: Plasma levels of endothelin-1 increase in patients with sarcoidosis and fall after disease remission. Panminerva Medica 43(4): 257-261
Simon, M.; Battistini, B.; Joo Kim, Y.; Tsang, J. 2003: Plasma levels of endothelin-1, big endothelin-1 and thromboxane following acute pulmonary air embolism. Respiratory Physiology and Neurobiology 138(1): 97-106
Mahaney, M.C.; Czerwinski, S.A.; Adachi, T.; Wilcken, D.E.; Wang, X.L. 2000: Plasma levels of extracellular superoxide dismutase in an Australian population: genetic contribution to normal variation and correlations with plasma nitric oxide and apolipoprotein A-i levels. Arteriosclerosis Thrombosis and Vascular Biology 20(3): 683-688
Cardigan, R.A.; Crook, M.; Mackie, I.J.; Machin, S.J. 2001: Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(3): 187-192
Peters, J.H.; Loredo, G.A.; Chen, G.; Maunder, R.; Hahn, T.J.; Willits, N.H.; Hynes, R.O. 2003: Plasma levels of fibronectin bearing the alternatively spliced EIIIB segment are increased after major trauma. Journal of Laboratory and Clinical Medicine 141(6): 401-410
Grieco, A.; Matera, A.; Di Rocco, P.; Marcoccia, S.; Giancaterini, A.; Alfei, B.; Addolorato, G.; Varlese, F.; Gasbarrini, G. 1998: Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease. Hepato-Gastroenterology 45(23): 1731-1736
Ozawa, Y.; Yoshizumi, M.; Inui, D.; Tsuchiya, K.; Houchi, H.; Tamaki, T.; Minakuchi, K. 1999: Plasma levels of free and sulfoconjugated catecholamines in patients with atherosclerosis. Biological and Pharmaceutical Bulletin 22(6): 657-659
Morange, P.E.; Renucci, J.F.; Charles, M.A.; Aillaud, M.F.; Giraud, F.; Grimaux, M.; Juhan-Vague, I. 2001: Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers. Thrombosis and Haemostasis 85(6): 999-1003
Ozcan, M.Ali.; Cömlekçi, A.; Demirkan, F.; Yüksel, F.; Sari, I.; Demir, T.; Ozsan, Güner.Hayri.; Orük, G.; Yeşil, S.; Undar, Bülent. 2003: Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thrombosis Research 110(4): 243-247
Santoro, A.; Rovati, L.C.; Follet, M.; Setnikar, I.; Caplain, H.; Gualano, V. 2000: Plasma levels of glyceryl trinitrate and dinitrates during application of three strengths of a new glyceryl trinitrate transdermal patch. Arzneimittel-Forschung 50(9): 786-794
Yoshimura, R.; Ueda, N.; Shinkai, K.; Nakamura, J. 2003: Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia. International Clinical Psychopharmacology 18(2): 107-111
van Doorn, J.; Ringeling, A.M.; Rikken, B.; van Buul-Offers, S.C. 2001: Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency. Hormone Research 55(3): 147-154
Van Doorn, J.; Cornelissen, A.J.; Van Buul-Offers, S.C. 2001: Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions. Clinical Endocrinology 54(5): 655-664
Yu, H.; Spitz, M.R.; Mistry, J.; Gu, J.; Hong, W.K.; Wu, X. 1999: Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. Journal of the National Cancer Institute 91(2): 151-156
Mazzone, A.; De Servi, S.; Vezzoli, M.; Fossati, G.; Mazzucchelli, I.; Gritti, D.; Ottini, E.; Mussini, A.; Specchia, G. 1999: Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145(2): 369-374
Ludwiczek, O.; Kaser, A.; Novick, D.; Dinarello, C.A.; Rubinstein, M.; Vogel, W.; Tilg, H. 2002: Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. Journal of Clinical Immunology 22(6): 331-337
Romagnoli, C.; Frezza, S.; Cingolani, A.; De Luca, A.; Puopolo, M.; De Carolis, M.P.; Vento, G.; Antinori, A.; Tortorolo, G. 2001: Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. European Journal of Pediatrics 160(6): 345-350
Shariat, S.F.; Andrews, B.; Kattan, M.W.; Kim, J.; Wheeler, T.M.; Slawin, K.M. 2001: Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 58(6): 1008-1015
Kubera, M.; Kenis, G.; Bosmans, E.; Zieba, A.; Dudek, D.; Nowak, G.; Maes, M. 2000: Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Polish Journal of Pharmacology 52(3): 237-241
Walsh, K.M.; Timms, P.; Campbell, S.; MacSween, R.N.; Morris, A.J. 1999: Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis. Digestive Diseases and Sciences 44(3): 624-630
Inokubo, Y.; Hanada, H.; Ishizaka, H.; Fukushi, T.; Kamada, T.; Okumura, K. 2001: Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. American Heart Journal 141(2): 211-217
Tokura, T.; Kinoshita, H.; Fujimoto, S.; Hisanaga, S.; Kitamura, K.; Eto, T. 2001: Plasma levels of mature form of adrenomedullin in patients with haemodialysis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 16(4): 783-786
Sangiorgi, G.; D'Averio, R.; Mauriello, A.; Bondio, M.; Pontillo, M.; Castelvecchio, S.; Trimarchi, S.; Tolva, V.; Nano, G.; Rampoldi, V.; Spagnoli, L.G.; Inglese, L. 2001: Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 104(12 Suppl 1): I288-I295
Yoshida, T.; Honda, A.; Matsuzaki, Y.; Shoda, J.; Abei, M.; Tanaka, N.; Osuga, T. 1999: Plasma levels of mevalonate and 7alpha-hydroxy-4-cholesten-3-one in chronic liver disease. Journal of Gastroenterology and Hepatology 14(2): 150-155
Mori, K.; Manabe, T.; Nii, M.; Hayabuchi, Y.; Kuroda, Y.; Tatara, K. 2002: Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatric Cardiology 23(2): 160-166
Holmström, H.; Hall, C.; Thaulow, E. 2001: Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatrica 90(2): 184-191
Hayakawa, H.; Komada, Y.; Hirayama, M.; Hori, H.; Ito, M.; Sakurai, M. 2001: Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Medical and Pediatric Oncology 37(1): 4-9
Monteleone, P.; Luisi, M.; Colurcio, B.; Casarosa, E.; Monteleone, P.; Ioime, R.; Genazzani, A.R.; Maj, M. 2001: Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosomatic Medicine 63(1): 62-68
Ikemoto, Y.; Teraguchi, M.; Kobayashi, Y. 2002: Plasma levels of nitrate in congenital heart disease: comparison with healthy children. Pediatric Cardiology 23(2): 132-136
Lavie, L.; Hefetz, A.; Luboshitzky, R.; Lavie, P. 2003: Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. Journal of Molecular Neuroscience: Mn 21(1): 57-63
Kohno, M.; Yokokawa, K.; Minami, M.; Yasunari, K.; Maeda, K.; Kano, H.; Hanehira, T.; Yoshikawa, J. 1999: Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension. Metabolism, Clinical and Experimental 48(10): 1256-1259
Licht, R.; van Bruggen, M.C.; Oppers-Walgreen, B.; Rijke, T.P.; Berden, J.H. 2001: Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration. Arthritis and Rheumatism 44(6): 1320-1330
Gambichler, T.; Bader, A.; Vojvodic, M.; Avermaete, A.; Schenk, M.; Altmeyer, P.; Hoffmann, K. 2002: Plasma levels of opioid peptides after sunbed exposures. British Journal of Dermatology 147(6): 1207-1211
Hatakeyama, Y.; Mizunashi, K.; Furukawa, Y.; Yabuki, S.; Sato, Y.; Igarashi, T. 2003: Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I. Journal of Clinical Endocrinology and Metabolism 88(5): 2250-2255
Bowyer, J.F.; Young, J.F.; Slikker, W.; Itzak, Y.; Mayorga, A.J.; Newport, G.D.; Ali, S.F.; Frederick, D.L.; Paule, M.G. 2003: Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations. Neurotoxicology 24(3): 379-390
Fujita, T.; Amuro, Y.; Hada, T.; Higashino, K. 1999: Plasma levels of pipecolic acid, both L- and D-enantiomers, in patients with chronic liver diseases, especially hepatic encephalopathy. Clinica Chimica Acta; International Journal of Clinical Chemistry 287(1-2): 99-109
Lindholt, J.S.; Jørgensen, B.; Fasting, H.; Henneberg, E.W. 2001: Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes. Journal of Vascular Surgery 34(4): 611-615
Buratti, T.; Ricevuti, G.; Pechlaner, C.; Joannidis, M.; Wiedermann, F.J.; Gritti, D.; Herold, M.; Wiedermann, C.J. 2001: Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation 25(2): 97-100
Waterworth, D.M.; Hubacek, J.A.; Pitha, J.; Kovar, J.; Poledne, R.; Humphries, S.E.; Talmud, P.J. 2000: Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster. Journal of Lipid Research 41(7): 1103-1109
Ryan, L.A.; Zheng, J.; Brester, M.; Bohac, D.; Hahn, F.; Anderson, J.; Ratanasuwan, W.; Gendelman, H.E.; Swindells, S. 2001: Plasma levels of soluble CD14 and tumor necrosis factor-alpha type Ii receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. Journal of Infectious Diseases 184(6): 699-706
De Milito, A.; Aleman, S.; Marenzi, R.; Sonnerborg, A.; Fuchs, D.; Zazzi, M.; Chiodi, F.; D, F. 2002: Plasma levels of soluble CD27: A simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. Clinical and Experimental Immunology 127(3): 486-494
Barbano, G.; Cappa, F.; Prigione, I.; Pistoia, V.; Cohen, A.; Chiesa, S.; Gusmano, R.; Perfumo, F. 2001: Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 16(9): 1807-1813
Ludwiczek, O.; Kaser, A.; Tilg, H. 2003: Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases. International Journal of Colorectal Disease 18(2): 142-147
Hoshimoto, K.; Hayashi, M.; Ohkura, T. 2001: Plasma levels of soluble Fas during normal pregnancy. Gynecologic and Obstetric Investigation 51(2): 96-98
Boomsma, M.M.; Stearns-Kurosawa, D.J.; Stegeman, C.A.; Raschi, E.; Meroni, P.L.; Kurosawa, S.; Tervaert, J.W.Cohen. 2002: Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis. Clinical and Experimental Immunology 128(1): 187-194
Tsai, S-Ying.; Lee, H-Chien.; Chen, C-Chicy.; Lee, C-Hsien. 2003: Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission. Journal of Psychiatric Research 37(3): 229-235
Ashina, M.; Bendtsen, L.; Jensen, R.; Ekman, R.; Olesen, J. 1999: Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache. Pain. Supplement 83(3): 541-547
Niitsu, N.; Okabe-Kado, J.; Nakayama, M.; Wakimoto, N.; Sakashita, A.; Maseki, N.; Motoyoshi, K.; Umeda, M.; Honma, Y. 2000: Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia. Blood 96(3): 1080-1086
Holmes, V.A.; Wallace, J.M.W.; Gilmore, W.S.; Mcfaul, P.; Alexander, H.D. 2003: Plasma levels of the immunomodulatory cytokine interleukin-10 during normal human pregnancy: A longitudinal study. Cytokine 21(6): 265-269
Fernández-Real, J.M.; Gutiérrez, C.; Ricart, W.; Castiñeira, M.J.; Vendrell, J.; Richart, C. 1999: Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects. Atherosclerosis 146(2): 321-327
Kavakli, K.; Canciani, M.Teresa.; Mannucci, P.Mannuccio. 2002: Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children. Pediatric Hematology and Oncology 19(7): 467-473
Wiman, B.; Andersson, T.; Hallqvist, J.; Reuterwall, C.; Ahlbom, A.; deFaire, U. 2000: Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arteriosclerosis Thrombosis and Vascular Biology 20(8): 2019-2023
Bertin, E.; Nguyen, P.; Guenounou, M.; Durlach, V.; Potron, G.; Leutenegger, M. 2000: Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes and Metabolism 26(3): 178-182
Thompson, M.A.; Witzig, T.E.; Kumar, S.; Timm, M.M.; Haug, J.; Fonseca, R.; Greipp, P.R.; Lust, J.A.; Rajkumar, S.Vincent. 2003: Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma. British Journal of Haematology 123(2): 305-308
Belgore, F.M.; Lip, G.Y.; Bareford, D.; Wadley, M.; Stonelake, P.; Blann, A.D. 2001: Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer. American Journal of Hematology 66(1): 59-61
Belgore, F.M.; Blann, A.D.; Li-Saw-Hee, F.L.; Beevers, D.G.; Lip, G.Y. 2001: Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension. American Journal of Cardiology 87(6): 805
Duque, J.L.; Loughlin, K.R.; Adam, R.M.; Kantoff, P.W.; Zurakowski, D.; Freeman, M.R. 1999: Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology 54(3): 523-527
Messele, T.; Brouwer, M.; Girma, M.; Fontanet, A.L.; Miedema, F.; Hamann, D.; Rinke de Wit, T.F. 2001: Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Clinical Immunology 98(2): 212-219
Nicoletti, G.; Crescibene, L.; Scornaienchi, M.; Bastone, L.; Bagala, A.; Napoli, I.D.; Caracciolo, M.; Quattrone, A. 2001: Plasma levels of vitamin E in Parkinson's disease. Archives of Gerontology and Geriatrics 33(1): 7-12, July/August
Ben-Haroush, A.; Harell, D.; Hod, M.; Bardin, R.; Kaplan, B.; Orvieto, R.; Bar, J. 2002: Plasma levels of vitamin e in pregnant women prior to the development of preeclampsia and other hypertensive complications. Gynecologic and Obstetric Investigation 54(1): 26-30
Wojakowski, W.; Gmiński, J. 2001: Plasma levels of von willebrand factor, endothelin-1, prostacyclin and thromboxane in children from families with high risk of premature coronary artery disease. Scandinavian Journal of Clinical and Laboratory Investigation 61(4): 317-323
Anderberg, U.M.; Liu, Z.; Berglund, L.; Nyberg, F. 1998: Plasma levels on nociceptin in female fibromyalgia syndrome patients. Zeitschrift fuer Rheumatologie 57(Suppl 2): 77-80
Vallejo, M.C.; Ramanathan, S. 2002: Plasma lidocaine concentrations are higher in twin compared to singleton newborns following epidural anesthesia for Cesarean delivery. Canadian Journal of Anaesthesia 49(7): 701-705
Inomata, S.; Tanaka, E.; Miyabe, M.; Kakiuchi, Y.; Nagashima, A.; Yamasaki, Y.; Nakayama, S.; Baba, Y.; Toyooka, H.; Okuyama, K.; Kohda, Y. 2001: Plasma lidocaine concentrations during continuous thoracic epidural anesthesia after clonidine premedication in children. Anesthesia and Analgesia 93(5): 1147-1151
Rousseau, G.F.; Oram, M.; Barrington, J.; Priston, M.; Swart, M. 2002: Plasma lidocaine concentrations following insertion of 2% lidocaine gel into the uterine cavity after uterine balloon thermal ablation. British Journal of Anaesthesia 89(6): 846-848
Fukuda, T.; Kakiuchi, Y.; Miyabe, M.; Okubo, N.; Yaguchi, Y.; Kohda, Y.; Toyooka, H. 2000: Plasma lidocaine, monoethylglycinexylidide, and glycinexylidide concentrations after epidural administration in geriatric patients. Regional Anesthesia and Pain Medicine 25(3): 268-273
Nagyova, A.; Sustrova, M.; Raslova, K. 1999: Plasma lipid and lipoprotein levels and LDL oxidation in subjects with Down syndrome. Biologia (Bratislava) 54(6): 719-723
Nicolosi, R.; Bell, S.J.; Bistrian, B.R.; Greenberg, I.; Forse, R.A.; Blackburn, G.L. 1999: Plasma lipid changes after supplementation with beta-glucan fiber from yeast. American Journal of Clinical Nutrition 70(2): 208-212
Brizzi, P.; Tonolo, G.; Carusillo, F.; Malaguarnera, M.; Maioli, M.; Musumeci, S. 2003: Plasma lipid composition and LDL oxidation. Clinical Chemistry and Laboratory Medicine 41(1): 56-60
McCann, B.S.; Benjamin, G.A.; Wilkinson, C.W.; Retzlaff, B.M.; Russo, J.; Knopp, R.H. 1999: Plasma lipid concentrations during episodic occupational stress. Annals of Behavioral Medicine: a Publication of the Society of Behavioral Medicine 21(2): 103-110
Monge, R.; Holst, I.; Faiges, F.; Rivero, A. 2000: Plasma lipid levels in 10- to 13-year-old Costa Rican elementary schoolchildren. Food and Nutrition Bulletin 21(3): 293-300
Williams, T.D.; Guglielmo, C.G.; Egeler, O.; Martyniuk, C.J. 1999: Plasma lipid metabolites provide information on mass change over several days in captive Western Sandpipers. Auk 116(4): 994-1000
Turk, H.M.; Sevinc, A.; Camci, C.; Cigli, A.; Buyukberber, S.; Savli, H.; Bayraktar, N. 2002: Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetologica 39(3): 117-122
Shahar, E.; Chambless, L.E.; Rosamond, W.D.; Boland, L.L.; Ballantyne, C.M.; McGovern, P.G.; Sharrett, A.R. 2003: Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 34(3): 623-631
Akeson, P.M.; Axelsson, I.E.; Räihä, N.C. 1999: Plasma lipids and apolipoproteins in breastfed and formula-fed Swedish infants. Acta Paediatrica 88(1): 1-6
Piñon, F.; Merino, J.F.; Ferrer, J.C.; Martínez, M.; Vayá, A.; Aznar, J. 2002: Plasma lipids and blood fluidity in patients with polygenic hypercholesterolaemia treated with fluvastatin. Clinical Hemorheology and Microcirculation 27(3-4): 193-199
Yamaguchi, T.; Sugimoto, T.; Yano, S.; Yamauchi, M.; Sowa, H.; Chen, Q.; Chihara, K. 2002: Plasma lipids and osteoporosis in postmenopausal women. Endocrine Journal 49(2): 211-217
Muntner, P.; Coresh, J.; Smith, J.C.; Eckfeldt, J.; Klag, M.J. 2000: Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney International 58(1): 293-301
Mahley, R.W.; Arslan, P.; Pekcan, G.; Pépin, G.M.; Ağaçdiken, A.; Karaağoğlu, N.; Rakicioğlu, N.; Nursal, B.; Dayanikli, P.; Palaoğlu, K.E.; Bersot, T.P. 2001: Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL. Journal of Lipid Research 42(12): 1996-2006
Tsuji, A.; Ikeda, N.; Nakamura, T. 1999: Plasma lipids, lipoproteins and apolipoproteins and sudden cardiac death. International Journal of Legal Medicine 112(3): 151-154
Polidori, M.Cristina.; Savino, K.; Alunni, G.; Freddio, M.; Senin, U.; Sies, H.; Stahl, W.; Mecocci, P. 2002: Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: Relationship to disease severity. Free Radical Biology and Medicine 32(2): 148-152
Erem, C.; Değer, O.; Bostan, M.; Orem, A.; Sönmez, M.; Ulusoy, S.; Telatar, M. 1999: Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications. Acta Cardiologica 54(4): 203-207
Nakahara, C.; Kobayashi, K.; Hamaguchi, H.; Kanemoto, K.; Kashiwagi, R.; Matsui, A. 1999: Plasma lipoprotein (a) levels in children with minimal lesion nephrotic syndrome. Pediatric Nephrology 13(8): 657-661
Lagrost, L.; Athias, A.; Lemort, N.; Richard, J.L.; Desrumaux, C.; Châtenet-Duchêne, L.; Courtois, M.; Farnier, M.; Jacotot, B.; Braschi, S.; Gambert, P. 1999: Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin. Atherosclerosis 143(2): 415-425
Mossab, A.; Guillaumin, S.; Lessire, M.; Milliat, F.; Hermier, D. 2001: Plasma lipoprotein distribution in the turkey (Meleagris gallopavo). Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 130(2): 227-235
Mekki, K.; Prost, J.; Bouchenak, M.; Remaoun, M.; Belleville, J. 2003: Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis. Atherosclerosis 169(2): 269-277
Nielsen, N.E.; Olsson, A.G.; Swahn, E. 2000: Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics. Journal of Internal Medicine 247(1): 43-52
Shcherbakova, L.N.; Kravchenko Berezhnaya, N.R.; Bessekeyev, A.A.; Molchanova, L.V. 2002: Plasma lipoprotein spectrum in patients with prior serious mechanical trauma. Anesteziologiya i Reanimatologiya 6: 19-22
Della Guardia, P.; Grossi, A.; Elisei, W.; Eramo, A.; de Santis, A.D.; Attili, A.F.; Genco, A.; Basso, N.; Ginanni Corradini, S.G. 1999: Plasma lipoproteins affect rate of cholesterol absorbed from bile by gallbladder: preliminary data. Italian Journal of Gastroenterology and Hepatology 31(7): 587-592
Okajima, F. 2002: Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: Is this an atherogenic mediator or an anti-atherogenic mediator?. Biochimica et Biophysica Acta 1582(1-3): 132-137
Kjalke, M.; Silveira, A.; Hamsten, A.; Hedner, U.; Ezban, M. 2000: Plasma lipoproteins enhance tissue factor-independent factor VII activation. Arteriosclerosis Thrombosis and Vascular Biology 20(7): 1835-1841
Kitchens, R.L.; Wolfbauer, G.; Albers, J.J.; Munford, R.S. 1999: Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. Journal of Biological Chemistry 274(48): 34116-34122
Goessl, A.; Golledge, S.L.; Hoffman, A.S. 2001: Plasma lithography--thin-film patterning of polymers by RF plasma polymerization II: Study of differential binding using adsorption probes. Journal of Biomaterials Science. Polymer Edition 12(7): 739-753
Kamoun, P.; Richard, V.; Rabier, D.; Saudubray, J.M. 2002: Plasma lysine concentration and availability of 2-ketoglutarate in liver mitochondria. Journal of Inherited Metabolic Disease 25(1): 1-6
Gönenç, A.; Ozkan, Y.; Torun, M.; Simşek, B. 2001: Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. Journal of Clinical Pharmacy and Therapeutics 26(2): 141-144
Totan, Y.; Cekiç, O.; Borazan, M.; Uz, E.; Sögüt, S.; Akyol, O. 2001: Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. British Journal of Ophthalmology 85(12): 1426-1428
Cella, G.; Bellotto, F.; Tona, F.; Sbarai, A.; Mazzaro, G.; Motta, G.; Fareed, J. 2001: Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120(4): 1226-1230
Schwarz, K.B.; Rosensweig, J.; Sharma, S.; Jones, L.; Durant, M.; Potter, C.; Narkewicz, M.R. 2003: Plasma markers of platelet activation in cystic fibrosis liver and lung disease. Journal of Pediatric Gastroenterology and Nutrition 37(2): 187-191
Jung, K.; Krell, H.-W.; Ortel, B.; Hasan, T.; Römer, A.; Schnorr, D.; Loening, S.A.; Lein, M. 2003: Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats. Prostate 54(3): 206-211
Wang, J.C.; Novetsky, A.; Chen, C.; Novetsky, A.D. 2002: Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis. British Journal of Haematology 119(3): 709-712
Jacob, M-Paule.; Cazaubon, Mèle.; Scemama, A.; Prié, D.; Blanchet, Fçoise.; Guillin, M-Claude.; Michel, J-Baptiste. 2002: Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation 106(5): 535-538
Ageno, W.; Finazzi, S.; Steidl, L.; Biotti, M.Grazia.; Mera, V.; Melzi D'Eril, G.; Venco, A. 2002: Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Archives of Internal Medicine 162(22): 2589-2593
Caglayan, S.; Ozata, M.; Ozisik, G.; Turan, M.; Bolu, E.; Oktenli, C.; Arslan, N.; Erbil, K.; Gul, D.; Ozdemir, I.C. 2001: Plasma melatonin concentration before and during testosterone replacement in Klinefelter's syndrome: relation to hepatic indolamine metabolism and sympathoadrenal activity. Journal of Clinical Endocrinology and Metabolism 86(2): 738-743
Estell, K.; Braunstein, G.; Tucker, T.; Varga, K.; Collawn, J.F.; Schwiebert, L.M. 2003: Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. Molecular and Cellular Biology 23(2): 594-606
DeMarco, S.J.; Chicka, M.C.; Strehler, E.E. 2002: Plasma membrane Ca2+ ATPase isoform 2b interacts preferentially with Na+/H+ exchanger regulatory factor 2 in apical plasma membranes. Journal of Biological Chemistry 277(12): 10506-10511
Filoteo, A.G.; Enyedi, A.; Verma, A.K.; Elwess, N.L.; Penniston, J.T. 2000: Plasma membrane Ca(2+) pump isoform 3f is weakly stimulated by calmodulin. Journal of Biological Chemistry 275(6): 4323-4328
Rychkov, G.; Brereton, H.M.; Harland, M.L.; Barritt, G.J. 2001: Plasma membrane Ca2+ release-activated Ca2+ channels with a high selectivity for Ca2+ identified by patch-clamp recording in rat liver cells. Hepatology 33(4): 938-947
Magyar, C.E.; White, K.E.; Rojas, R.; Apodaca, G.; Friedman, P.A. 2002: Plasma membrane Ca2+-ATPase and NCX1 Na+/Ca2+ exchanger expression in distal convoluted tubule cells. American Journal of Physiology. Renal Physiology 283(1): F29-F40
Zabe, M.; Dean, W.L. 2001: Plasma membrane Ca(2+)-ATPase associates with the cytoskeleton in activated platelets through a PDZ-binding domain. Journal of Biological Chemistry 276(18): 14704-14709
Dumont, R.A.; Lins, U.; Filoteo, A.G.; Penniston, J.T.; Kachar, B.; Gillespie, P.G. 2001: Plasma membrane Ca2+-ATPase isoform 2a is the PMCA of hair bundles. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(14): 5066-5078
Wan, T.C.; Zabe, M.; Dean, W.L. 2003: Plasma membrane Ca2+-ATPase isoform 4b is phosphorylated on tyrosine 1176 in activated human platelets. Thrombosis and Haemostasis 89(1): 122-131
DeMarco, S.J.; Strehler, E.E. 2001: Plasma membrane Ca2+-atpase isoforms 2b and 4b interact promiscuously and selectively with members of the membrane-associated guanylate kinase family of PDZ (PSD95/Dlg/ZO-1) domain-containing proteins. Journal of Biological Chemistry 276(24): 21594-21600
Delgado-Coello, B.; Santiago-García, J.; Zarain-Herzberg, A.; Mas-Oliva, J. 2003: Plasma membrane Ca2+-ATPase mRNA expression in murine hepatocarcinoma and regenerating liver cells. Molecular and Cellular Biochemistry 247(1-2): 177-184
Kamagate, A.; Herchuelz, A.é; Van Eylen, F.ço. 2002: Plasma membrane Ca(2+)-ATPase overexpression reduces Ca(2+) oscillations and increases insulin release induced by glucose in insulin-secreting BRIN-BD11 cells. Diabetes 51(9): 2773-2788
Pászty, K.; Verma, A.K.; Padányi, R.; Filoteo, A.G.; Penniston, J.T.; Enyedi, A. 2002: Plasma membrane Ca2+ATPase isoform 4b is cleaved and activated by caspase-3 during the early phase of apoptosis. Journal of Biological Chemistry 277(9): 6822-6829
Deken, S.L.; Wang, D.; Quick, M.W. 2003: Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(5): 1563-1568
Jahn, T.; Baluska, F.; Michalke, W.; Harper, J.F.; Volkmann, D. 1998: Plasma membrane H+-ATPase in the root apex: Evidence for strong expression in xylem parenchyma and asymmetric localization within cortical and epidermal cells. Physiologia Plantarum 104(3): 311-316
Cai, Y.Y.; Zhang Hong, M. Chen Jia 1999: Plasma membrane NADPH oxidase in tobacco-tobacco mosaic virus interaction. Acta Botanica Sinica 41(10): 1094-1098
Bottalico, B.; Pilka, R.; Larsson, I.; Casslen, B.; Marsal, K.; Hansson, S.R. 2003: Plasma membrane and vesicular monoamine transporters in normal endometrium and early pregnancy decidua. Molecular Human Reproduction 9(7): 389-394
Sailer, R.; Strauss, W.S.; Emmert, H.; Stock, K.; Steiner, R.; Schneckenburger, H. 2000: Plasma membrane associated location of sulfonated meso-tetraphenylporphyrins of different hydrophilicity probed by total internal reflection fluorescence spectroscopy. Photochemistry and Photobiology 71(4): 460-465
Sinha, A.A.; Jamuar, M.P.; Wilson, M.J.; Rozhin, J.; Sloane, B.F. 2001: Plasma membrane association of cathepsin B in human prostate cancer: Biochemical and immunogold electron microscopic analysis. Prostate 49(3): 172-184
Meiser, A.; Sancho, C.; Krijnse Locker, J. 2003: Plasma membrane budding as an alternative release mechanism of the extracellular enveloped form of vaccinia virus from Hela cells. Journal of Virology 77(18): 9931-9942
Bian, L.; Zeng, J.; Borchman, D.; Paterson, C.A. 2000: Plasma membrane calcium ATPase gene expression in bovine lens epithelium. Ophthalmic Research 32(2-3): 100-105
Gros, R.; Afroze, T.; You, X-Mang.; Kabir, G.; Van Wert, R.; Kalair, W.; Hoque, A.E.; Mungrue, I.N.; Husain, M. 2003: Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure. Circulation Research 93(7): 614-621
Garcia, M.L.; Usachev, Y.M.; Thayer, S.A.; Strehler, E.E.; Windebank, A.J. 2001: Plasma membrane calcium ATPase plays a role in reducing Ca(2+)-mediated cytotoxicity in PC12 cells. Journal of Neuroscience Research 64(6): 661-669
Garcia, M.L.; Strehler, E.E. 1999: Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function. Frontiers in Bioscience: a Journal and Virtual Library 4: D869-D882
Kaznacheyeva, E.; Zubov, A.; Nikolaev, A.; Alexeenko, V.; Bezprozvanny, I.; Mozhayeva, G.N. 2000: Plasma membrane calcium channels in human carcinoma A431 cells are functionally coupled to inositol 1,4,5-trisphosphate receptor-phosphatidylinositol 4,5-bisphosphate complexes. Journal of Biological Chemistry 275(7): 4561-4564
Bhargava, A.; Meijer, O.C.; Dallman, M.F.; Pearce, D. 2000: Plasma membrane calcium pump isoform 1 gene expression is repressed by corticosterone and stress in rat hippocampus. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(9): 3129-3138
Arispe, N.; Doh, M. 2002: Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 16(12): 1526-1536
Park, H.; Go, Y.M.; St John, P.L.; Maland, M.C.; Lisanti, M.P.; Abrahamson, D.R.; Jo, H. 1998: Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. Journal of Biological Chemistry 273(48): 32304-32311
Patel, H.K.; Willhite, D.C.; Patel, R.M.; Ye, D.; Williams, C.L.; Torres, E.M.; Marty, K.B.; MacDonald, R.A.; Blanke, S.R. 2002: Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin. Infection and Immunity 70(8): 4112-4123
Zager, R.A. 2000: Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack. Kidney International 58(1): 193-205
Millot, C.; Le Berre-Anton, V.; Tocanne, J.F.; Tournier, J.F. 2000: Plasma membrane coating with cationic silica particles and osmotic shock alters the morphology of bovine aortic endothelial cells. Biochimica et Biophysica Acta 1467(1): 85-90
Gomez-Diaz, C.; Barroso, M.P.; Navas, P. 2000: Plasma membrane coenzyme Q10 and growth control. Protoplasma 214(1-2): 19-23
Blaschuk, O.W.; Rowlands, T.M. 2002: Plasma membrane components of adherens junctions (Review). Molecular Membrane Biology 19(2): 75-80
Liu, Y.; Zhang, J.; Xu, Z.; Li, X.; Zhao, D.; Cui, X.; Bai, W.; Wang, T.; Yang, J.; Iwamoto, Y.; Tsushima, T. 2000: Plasma membrane content of glucose transporter 4 in skeletal muscle and visceral fat in OLETF rats treated with troglitazone. Journal of Health Science 46(6): 441-446
Scott, K.D.; Stafford, J.L.; Galvez, F.; Belosevic, M.; Goss, G.G. 2003: Plasma membrane depolarization reduces nitric oxide (NO) production in P388D.1 macrophage-like cells during Leishmania major infection. Cellular Immunology 222(1): 58-68
Bortner, C.D.; Gomez-Angelats, M.; Cidlowski, J.A. 2001: Plasma membrane depolarization without repolarization is an early molecular event in anti-Fas-induced apoptosis. Journal of Biological Chemistry 276(6): 4304-4314
Orellana, M.F.; Smith, A.K.; Waller, J.L.; DeLeon, E.; Borke, J.L. 2002: Plasma membrane disruption in orthodontic tooth movement in rats. Journal of Dental Research 81(1): 43-47
Saito, K.; Miyake, K.; McNeil, P.L.; Kato, K.; Yago, K.; Sugai, N. 1999: Plasma membrane disruption underlies injury of the corneal endothelium by ultrasound. Experimental Eye Research 68(4): 431-437
Katz, A.; Pick, U. 2001: Plasma membrane electron transport coupled to Na(+) extrusion in the halotolerant alga Dunaliella. Biochimica et Biophysica Acta 1504(2-3): 423-431
Wyckoff, M.H.; Chambliss, K.L.; Mineo, C.; Yuhanna, I.S.; Mendelsohn, M.E.; Mumby, S.M.; Shaul, P.W. 2001: Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). Journal of Biological Chemistry 276(29): 27071-27076
Razandi, M.; Pedram, A.; Levin, E.R. 2000: Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Molecular Endocrinology 14(9): 1434-1447
Belles, C.; Kuhl, A.; Nosheny, R.; Carding, S.R. 1999: Plasma membrane expression of heat shock protein 60 in vivo in response to infection. Infection and Immunity 67(8): 4191-4200
Kantar, A.; Littarru, G.P.; Falcioni, G.; Cherubini, V.; Coppa, G.V.; Fiorini, R. 1999: Plasma membrane fluidity and polarity of polymorphonuclear leukocytes from children with type I diabetes mellitus. Journal of Diabetes and its Complications 13(5-6): 243-250
Rodriguez, J.A.; Piddini, E.; Hasegawa, T.; Miyagi, T.; Dotti, C.G. 2001: Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(21): 8387-8395
Rojas, M.V.; Esponda, P. 2001: Plasma membrane glycoproteins during spermatogenesis and in spermatozoa of some fishes. Journal of Submicroscopic Cytology and Pathology 33(1-2): 133-140
Lin, M.H.; Morshedi, M.; Srisombut, C.; Nassar, A.; Oehninger, S. 1998: Plasma membrane integrity of cryopreserved human sperm: An investigation of the results of the hypoosmotic swelling test, the water test, and eosin-Y staining. Fertility and Sterility 70(6): 1148-1155
Quartacci, M.F.; Glisić, O.; Stevanović, B.; Navari-Izzo, F. 2002: Plasma membrane lipids in the resurrection plant Ramonda serbica following dehydration and rehydration. Journal of Experimental Botany 53(378): 2159-2166
Li, L.; Haynes, M.Page.; Bender, J.R. 2003: Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 100(8): 4807-4812
Babu, P.; Bryan, J.D.; Panek, H.R.; Jordan, S.L.; Forbrich, B.M.; Kelley, S.C.; Colvin, R.T.; Robinson, L.C. 2002: Plasma membrane localization of the Yck2p yeast casein kinase 1 isoform requires the C-terminal extension and secretory pathway function. Journal of Cell Science 115(Pt 24): 4957-4968
Clarke, M.-Sf; Prendergast, M., A.; Terry, A., V.,. Jr.; 1999: Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats. Learning and Memory (Cold Spring Harbor) 6(6): 634-649
Kusumi, A. 1998: Plasma membrane organization by the membrane skeleton. Kongelige Danske Videnskabernes Selskab Biologiske Skrifter 49: 137-142
Santroni, A.M.; Fadeli, D.; Zolese, G.; Gabbianelli, R.; Falcioni, G. 1999: Plasma membrane perturbation induced by tributyltin chloride on density-separated trout erythrocytes. Applied Organometallic Chemistry 13(10): 777-781
Chan, A.; Reiter, R.; Wiese, S.; Fertig, G.; Gold, R. 1998: Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models. Histochemistry and Cell Biology 110(6): 553-558
Zager, R.A.; Sacks, B.M.; Burkhart, K.M.; Williams, A.C. 1999: Plasma membrane phospholipid integrity and orientation during hypoxic and toxic proximal tubular attack. Kidney International 56(1): 104-117
Nanjundan, M.; Sun, J.; Zhao, J.; Zhou, Q.; Sims, P.J.; Wiedmer, T. 2003: Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor. Journal of Biological Chemistry 278(39): 37413-37418
Schillers, H.; Danker, T.; Schnittler, H.J.; Lang, F.; Oberleithner, H. 2000: Plasma membrane plasticity of Xenopus laevis oocyte imaged with atomic force microscopy. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 10(1-2): 99-107
Fiorini, R.; Littarru, G.P.; Coppa, G.V.; Kantar, A. 2000: Plasma membrane polarity of polymorphonuclear leucocytes from children with primary ciliary dyskinesia. European Journal of Clinical Investigation 30(6): 519-525
Livescu, A.; Manda, G.; Constantin, C.; Neagu, M.; Iordachescu, D. 2003: Plasma membrane potential interferes with the respiratory burst of peripheral granulocytes. Journal of Cellular and Molecular Medicine 7(1): 73-78
Lagerberg, J.W.; Uberriegler, K.P.; Krammer, B.; VanSteveninck, J.; Dubbelman, T.M. 2000: Plasma membrane properties involved in the photodynamic efficacy of merocyanine 540 and tetrasulfonated aluminum phthalocyanine. Photochemistry and Photobiology 71(3): 341-346
Schillers, H.; Danker, T.; Madeja, M.; Oberleithner, H. 2001: Plasma membrane protein clusters appear in CFTR-expressing Xenopus laevis oocytes after cAMP stimulation. Journal of Membrane Biology 180(3): 205-212
Bagnat, M.; Chang, A.; Simons, K. 2001: Plasma membrane proton ATPase Pma1p requires raft association for surface delivery in yeast. Molecular Biology of the Cell 12(12): 4129-4138
Weiler, P.J.; Wiebe, J.P. 2000: Plasma membrane receptors for the cancer-regulating progesterone metabolites, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-4-pregnen-20-one in MCF-7 breast cancer cells. Biochemical and Biophysical Research Communications 272(3): 731-737
Zakharenko, S.; Popov, S. 2000: Plasma membrane recycling and flow in growing neurites. Neuroscience 97(1): 185-194
Del Valle, A.E.; Del Castillo Olivares, A.; Sanchez Jimenez, F.; Marquez, J.; Nunez, D.C.stro, I.; Medina, M.A. 1998: Plasma membrane redox system activity in tumour cell lines of mammary origins with different proliferation rates. Protoplasma 205(1-4): 169-173
Browne, H.; Bruun, B.; Minson, T. 2001: Plasma membrane requirements for cell fusion induced by herpes simplex virus type 1 glycoproteins gB, gD, gH and gL. Journal of General Virology 82(Pt 6): 1419-1422
Koticha, D.K.; McCarthy, E.E.; Baldini, G. 2002: Plasma membrane targeting of SNAP-25 increases its local concentration and is necessary for SNARE complex formation and regulated exocytosis. Journal of Cell Science 115(Part 16): 3341-3351
Kotwicka, M.; Jendraszak, M.; Warchoł, J.B. 2002: Plasma membrane translocation of phosphatidylserine in human spermatozoa. Folia Histochemica et Cytobiologica 40(2): 111-112
Delrot, S.; Atanassova, R.; Gomes, E.; Coutos Thevenot, P. 2001: Plasma membrane transporters: A machinery for uptake of organic solutes and stress resistance. Plant Science (Shannon) 161(3): 391-404
Bahamonde, M.I.; Fernández-Fernández, J.é M.; Guix, F.X.; Vázquez, E.; Valverde, M.A. 2003: Plasma membrane voltage-dependent anion channel mediates antiestrogen-activated maxi Cl- currents in C1300 neuroblastoma cells. Journal of Biological Chemistry 278(35): 33284-33289
Collings; Asada; Allen; Shibaoka 1998: Plasma membrane-associated actin in bright yellow 2 tobacco cells. Evidence for interaction with microtubules. Plant Physiology 118(3): 917-928
Ilić, D.; Genbacev, O.; Jin, F.; Caceres, E.; Almeida, E.A.; Bellingard-Dubouchaud, V.; Schaefer, E.M.; Damsky, C.H.; Fisher, S.J. 2001: Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro. American Journal of Pathology 159(1): 93-108
Devi, K.U.; Jha, K.; Shivaji, S. 1999: Plasma membrane-associated protein tyrosine phosphatase activity in hamster spermatozoa. Molecular Reproduction and Development 53(1): 42-50
Cleary, A.L. 2001: Plasma membrane-cell wall connections: roles in mitosis and cytokinesis revealed by plasmolysis of Tradescantia virginiana leaf epidermal cells. Protoplasma 215(1-4): 21-34
Gametchu, B.; Chen, F.; Sackey, F.; Powell, C.; Watson, C.S. 1999: Plasma membrane-resident glucocorticoid receptors in rodent lymphoma and human leukemia models. Steroids 64(1-2): 107-119
Jenni-Eiermann, S.; Jenni, L.; Piersma, T. 2002: Plasma metabolites reflect seasonally changing metabolic processes in a long-distance migrant shorebird (Calidris canutus). Zoology 105(3): 239-246
Farias, E.; Ranuncolo, S.; Cresta, C.; Specterman, S.; Armanasco, E.; Varela, M.; Lastiri, J.; Pallotta, M.G.; Bal de Kier Joffe, E.; Puricelli, L. 2000: Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. International Journal of Cancer 89(4): 389-394
Castellanos, M.; Leira, R.; Serena, Jín.; Pumar, Jé.M.; Lizasoain, I.; Castillo, Jé.; Dávalos, A. 2003: Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 34(1): 40-46
Eisenhofer, G.; Walther, M.; Keiser, H.R.; Lenders, J.W.; Friberg, P.; Pacak, K. 2000: Plasma metanephrines: a novel and cost-effective test for pheochromocytoma. Brazilian Journal of Medical and Biological Research 33(10): 1157-1169
Torrens, M.; Castillo, C.; San, L.; del Moral, E.; González, M.L.; de la Torre, R. 1998: Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. Drug and Alcohol Dependence 52(3): 193-200
van Goozen, S.H.; Matthys, W.; Cohen-Kettenis, P.T.; Westenberg, H.; van Engeland, H. 1999: Plasma monoamine metabolites and aggression: Two studies of normal and oppositional defiant disorder children. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 9(1-2): 141-147
Ellingsen, T.; Buus, A.; Stengaard-Pedersen, K. 2001: Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis. Journal of Rheumatology 28(1): 41-46
Kimura, H.; Okada, O.; Tanabe, N.; Tanaka, Y.; Terai, M.; Takiguchi, Y.; Masuda, M.; Nakajima, N.; Hiroshima, K.; Inadera, H.; Matsushima, K.; Kuriyama, T. 2001: Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 164(2): 319-324
Oshima, S.; Ogawa, H.; Hokimoto, S.; Nakamura, S.; Noda, K.; Saito, T.; Soejima, H.; Takazoe, K.; Ishibashi, F.; Yasue, H. 2001: Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation. Japanese Circulation Journal 65(4): 261-264
Sjölund, K.; Ekman, R. 2003: Plasma motilin in untreated celiac disease. Peptides 24(3): 483-486
Grulke, S.; Benbarek, H.; Caudron, I.; Deby-Dupont, G.; Mathy-Hartert, M.; Farnir, F.; Deby, C.; Lamy, M.; Serteyn, D. 1999: Plasma myeloperoxidase level and polymorphonuclear leukocyte activation in horses suffering from large intestinal obstruction requiring surgery: preliminary results. Canadian Journal of Veterinary Research 63(2): 142-147
McDonald, T.; Berkowitz, R.; Hoffman, W.E. 2000: Plasma naltrexone during opioid detoxification. Journal of Addictive Diseases 19(4): 59-64
Wu, X.; Seino, Y.; Ogura, H.; Fukuma, N.; Katoh, T.; Takano, T. 2001: Plasma natriuretic peptide levels and daily physical activity in patients with pacemaker implantation. Japanese Heart Journal 42(4): 471-482
Sutton, T.M.; Stewart, R.A.H.; Gerber, I.L.; West, T.M.; Richards, A.Mark.; Yandle, T.G.; Kerr, A.J. 2003: Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. Journal of the American College of Cardiology 41(12): 2280-2287
Vasan, R.S.; Benjamin, E.J.; Larson, M.G.; Leip, E.P.; Wang, T.J.; Wilson, P.W.F.; Levy, D. 2002: Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288(10): 1252-1259
Akagi, S.; Nagake, Y.; Sugimoto, T.; Nakao, K.; Yamasaki, H.; Ichikawa, H.; Makino, H. 2002: Plasma neuropeptide Y concentrations in patients on hemodialysis. Nephron 92(2): 333-338
Morgan, C.A.; Wang, S.; Southwick, S.M.; Rasmusson, A.; Hazlett, G.; Hauger, R.L.; Charney, D.S. 2000: Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biological Psychiatry 47(10): 902-909
Bozzola, M.; Thome, A.N.; Giraldi, E.; Lhiaubet, A.M.; Schimpff, R.M. 1998: Plasma neurotensin levels in prepubertal children and adults: possible involvement in the regulation of growth hormone secretion. Journal of Pediatric Endocrinology and Metabolism: Jpem 11(5): 615-621
Lechin, F.; Van Der Dijs, B.; Lechin, M.E.; Orozco, B.; Baez, S.; Lechin, A.E.; Jahn, E.; Jimenez, V. 1997: Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis, and moderate exercise conditions in two types of hypertensive patients. Research Communications in Biological Psychology and Psychiatry 22(3-4): 97-112
Lechin, F.; Van-Der-Dijs, B.; Jara, H.; Orozco, B.; Baez, S.; Jahn, E.; Benaim, M.; Lechin, E.; Lechin, M., E.; Jimenez, V.; Lechin, A., E. 1997: Plasma neurotransmttter profiles of anxiety, phobia and panic disorder patients. Acute and chronic effects of buspirone. Research Communications in Biological Psychology and Psychiatry 22(3-4): 113-156
Sveger, T.; Ohlsson, K.; Mörse, H.; Polberger, S.; Laurin, S. 2003: Plasma neutrophil lipocalin, elastase-alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scandinavian Journal of Clinical and Laboratory Investigation 63(2): 89-92
Shoaib, M.; Stolerman, I.P. 1999: Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats. Psychopharmacology 143(3): 318-321
Osorio, J.C.; Xu, X.; Vogel, T.; Ochoa, M.; Laycock, S.; Hintze, T.H. 2001: Plasma nitrate accumulation during the development of pacing-induced dilated cardiac myopathy in conscious dogs is due to renal impairment. Nitric Oxide: Biology and Chemistry 5(1): 7-17
Ahrén, C.; Jungersten, L.; Sandberg, T. 1999: Plasma nitrate as an index of nitric oxide formation in patients with acute infectious diseases. Scandinavian Journal of Infectious Diseases 31(4): 405-407
Charmandari, E.; Meadows, N.; Patel, M.; Johnston, A.; Benjamin, N. 2001: Plasma nitrate concentrations in children with infectious and noninfectious diarrhea. Journal of Pediatric Gastroenterology and Nutrition 32(4): 423-427
Suzuki, E.; Nakaki, T.; Nakamura, M.; Miyaoka, H. 2003: Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia. Journal of Psychiatry and Neuroscience: Jpn 28(4): 288-292
Kawakatsu, M.; Ishihara, T.; Kani, K.; Nakagawa, A.; Hiura, M.; Hazui, H.; Okabe, T.; Hoshiga, M.; Waku, S.; IIda, N.; Hanafusa, T. 2002: Plasma nitrate/nitrite concentration in healthy population and patients with diabetes mellitus: Relationships with gender, aging and diabetic complications. Bulletin of the Osaka Medical College 48(1-2): 1-6
Xiao, D.S.; Qian, Z.M. 2000: Plasma nitric oxide and iron concentrations in exercised rats are negatively correlated. Molecular and Cellular Biochemistry 208(1-2): 163-166
Yoon, Y.; Song, J.; Hong, S.H.; Kim, J.Q. 2000: Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clinical Chemistry 46(10): 1626-1630
Choi, I.C.; Fung, P.C.; Leung, A.Y.; Lie, A.K.; Liang, R. 2001: Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients. Haematologica 86(9): 972-976
Yu, C.M.; Fung, P.C.; Chan, G.; Lai, K.W.; Wang, Q.; Lau, C.P. 2001: Plasma nitric oxide level in heart failure secondary to left ventricular diastolic dysfunction. American Journal of Cardiology 88(8): 867-870
Yoneyama, Y.; Suzuki, S.; Sawa, R.; Miura, A.; Doi, D.; Otsubo, Y.; Araki, T. 2002: Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia. American Journal of Obstetrics and Gynecology 187(3): 676-680
Mutlu-Türkoglu, U.; Aykaç-Toker, G.; Ibrahimoglu, L.; Ademoglu, E.; Uysal, M. 1999: Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecologic and Obstetric Investigation 48(4): 247-250
Takaya, J.; Ikemoto, Y.; Teraguchi, M.; Nogi, S.; Kobayashi, Y. 2000: Plasma nitric oxide products correlate with cardiac index of congenital heart disease. Pediatric cardiology 21(4): 378-381
Kleinbongard, P.; Dejam, Aé.; Lauer, T.; Rassaf, T.; Schindler, A.; Picker, O.; Scheeren, T.; Gödecke, A.; Schrader, Jürgen.; Schulz, R.; Heusch, G.; Schaub, Günter.A.; Bryan, N.S.; Feelisch, M.; Kelm, M. 2003: Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radical Biology and Medicine 35(7): 790-796
Figueras-Aloy, J.; Gómez, L.; Rodríguez-Miguélez, J.M.; Jordán, Y.; Salvia, M.D.; Jiménez, W.; Carbonell-Estrany, X. 2003: Plasma nitrite/nitrate and endothelin-1 concentrations in neonatal sepsis. Acta Paediatrica 92(5): 582-587
Moriyama, A.; Tabaru, A.; Unoki, H.; Abe, S.; Masumoto, A.; Otsuki, M. 2000: Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma. Clinica Chimica Acta; International Journal of Clinical Chemistry 296(1-2): 181-191
Chuang, C.Y.; Hung, J.C.; Yang, C.Y.; Ma, Y.C.; Sung, F.C. 2003: Plasma nitrogen oxides levels in taxi drivers and community residents. Bulletin of environmental contamination and toxicology 70(3): 430-436
Rassaf, T.; Kleinbongard, P.; Preik, M.; Dejam, Aé.; Gharini, P.; Lauer, T.; Erckenbrecht, J.; Duschin, A.; Schulz, R.; Heusch, G.; Feelisch, M.; Kelm, M. 2002: Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical Study on the fate of NO in human blood. Circulation Research 91(6): 470-477
Cottrill, R.A.; Mckinley, R.S.; Van Der Kraak, G.; Dutil, J.D.; Reid, K.B.; Mcgrath, K.J. 2001: Plasma non-esterified fatty acid profiles and 17beta-oestradiol levels of juvenile immature and maturing adult American eels in the St Lawrence River. Journal of Fish Biology 59(2): 364-379
Leaf, A. 2001: Plasma nonesterified fatty acid concentration as a risk factor for sudden cardiac death: the Paris Prospective Study. Circulation 104(7): 744-745
Kazzam, E.; Caidahl, K.; Hedner, T.; Hedner, J.; Waldenström, A. 1999: Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis. Scandinavian Journal of Rheumatology 28(4): 238-243
Cooper, S.J.; Kelly, C.B. 2000: Plasma noradrenaline response to a cognitive stressor in subtypes of depressive illness. Human Psychopharmacology 15(4): 265-274
Johnston, T.G.; Kelly, C.B.; Stevenson, M.R.; Cooper, S.J. 1999: Plasma norepinephrine and prediction of outcome in major depressive disorder. Biological Psychiatry 46(9): 1253-1258
Zoccali, C.; Mallamaci, F.; Parlongo, S.; Cutrupi, S.; Benedetto, F.Antonio.; Tripepi, G.; Bonanno, G.; Rapisarda, F.; Fatuzzo, P.; Seminara, G.; Cataliotti, A.; Stancanelli, B.; Malatino, L.Salvatore.; Cateliotti, A. 2002: Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105(11): 1354-1359
Kelly, C.B.; Cooper, S.J. 1998: Plasma norepinephrine response to a cold pressor test in subtypes of depressive illness. Psychiatry Research 81(1): 39-50
Eisenhofer, G.; Lenders, J.W.; Linehan, W.M.; Walther, M.M.; Goldstein, D.S.; Keiser, H.R. 1999: Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New England Journal of Medicine 340(24): 1872-1879
Johnson, P.J.; Lo, Y.M.Dennis. 2002: Plasma nucleic acids in the diagnosis and management of malignant disease. Clinical Chemistry 48(8): 1186-1193
Geisler, J.; Omsjø, I.H.; Helle, S.I.; Ekse, D.; Silsand, T.; Lønning, P.E. 1999: Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. Journal of Endocrinology 162(2): 265-270
Fernández-Real, J.M.; Sanchis, D.; Ricart, W.; Casamitjana, R.; Balada, F.; Remesar, X.; Alemany, M. 1999: Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans. Clinical Endocrinology 50(2): 253-260
Sugimoto, T.; Nagake, Y.; Sugimoto, S.; Akagi, S.; Ichikawa, H.; Nakamura, Y.; Ogawa, N.; Makino, H. 2002: Plasma orexin concentrations in patients on hemodialysis. Nephron 90(4): 379-383
Higuchi, S.; Usui, A.; Murasaki, M.; Matsushita, S.; Nishioka, N.; Yoshino, A.; Matsui, T.; Muraoka, H.; Ishizuka, Y.; Kanba, S.; Sakurai, T. 2002: Plasma orexin-A is lower in patients with narcolepsy. Neuroscience Letters 318(2): 61-64
Matsumura, T.; Nakayama, M.; Satoh, H.; Naito, A.; Kamahara, K.; Sekizawa, K. 2003: Plasma orexin-A levels and body composition in COPD. Chest 123(4): 1060-1065
Nishijima, T.; Sakurai, S.; Arihara, Z.; Takahashi, K. 2003: Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome. Peptides 24(3): 407-411
Laden, F.; Hankinson, S.E.; Wolff, M.S.; Colditz, G.A.; Willett, W.C.; Speizer, F.E.; Hunter, D.J. 2001: Plasma organochlorine levels and the risk of breast cancer: an extended follow-up in the Nurses' Health Study. International Journal of Cancer 91(4): 568-574
Heenan, A.P.; Wolfe, L.A. 2003: Plasma osmolality and the strong ion difference predict respiratory adaptations in pregnant and nonpregnant women. Canadian Journal of Physiology and Pharmacology 81(9): 839-847
Xu, Z.; Nijland, M.J.; Ross, M.G. 2001: Plasma osmolality dipsogenic thresholds and c-fos expression in the near-term ovine fetus. Pediatric Research 49(5): 678-685
Matsuura, N.; Uchio, E.; Nakazawa, M.; Minami, M.; Uede, T.; Aoki, K.; Ohno, S. 2002: Plasma osteopontin levels in patients with allergic conjunctivitis or vernal keratoconjunctivitis. Rinsho Ganka 56(5): 893-896
Hotte, S.J.; Winquist, E.W.; Stitt, L.; Wilson, S.M.; Chambers, A.F. 2002: Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer 95(3): 506-512
Nordin Fredrikson, G.; Hedblad, B.; Berglund, G.; Nilsson, J. 2003: Plasma oxidized LDL: a predictor for acute myocardial infarction?. Journal of Internal Medicine 253(4): 425-429
Tsutsui, T.; Tsutamoto, T.; Wada, A.; Maeda, K.; Mabuchi, N.; Hayashi, M.; Ohnishi, M.; Kinoshita, M. 2002: Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. Journal of the American College of Cardiology 39(6): 957-962
Lee, R.; Garcia, F.; van de Kar, L.D.; Hauger, R.D.; Coccaro, E.F. 2003: Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. Psychiatry Research 118(2): 129-136
Anderberg, U.M.; Uvnas Moberg, K. 2000: Plasma oxytocin levels in female fibromyalgia syndrome patients. Zeitschrift fuer Rheumatologie 59(6): 373-379
Peracchi, M.; Tagliabue, R.; Quatrini, M.; Reschini, E. 1999: Plasma pancreatic polypeptide response to secretin. European Journal of Endocrinology 141(1): 47-49
Hansen, T.G.; O'brien, K.; Morton, N.S.; Rasmussen, S.N. 1999: Plasma paracetamol concentrations and pharmacokinetics following rectal administration in neonates and young infants. Acta Anaesthesiologica Scandinavica 43(8): 855-859
Chudek, J.; Karkoszka, H.; Schmidt-Gayk, H.; Ritz, E.; Kokot, F. 2000: Plasma parathyroid hormone, phosphatemia and vitamin D receptor genotype: are they interrelated?. Journal of Nephrology 13(1): 54-58
Sanaka, T.; Funaki, T.; Tanaka, T.; Hoshi, S.; Niwayama, J.; Taitoh, T.; Nishimura, H.; Higuchi, C. 2002: Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure. Nephron 91(1): 64-73
Watts, A.; Foley, A.; Awwad, M.; Treter, S.; Oravec, G.; Buhler, L.; Alwayn, I.P.; Kozlowski, T.; Lambrigts, D.; Gojo, S.; Basker, M.; White-Scharf, M.E.; Andrews, D.; Sachs, D.H.; Cooper, D.K. 2000: Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: Experience with 320 aphereses in baboons. Xenotransplantation 7(3): 181-185
Supko, J.G.; Garcia-Carbonero, R.; Puchalski, T.A.; Malspeis, L. 2001: Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs. Cancer Chemotherapy and Pharmacology 48(3): 202-208
Fox, E.; Murphy, R.F.; McCully, C.L.; Adamson, P.C. 2001: Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates. Cancer ChemoTherapy and Pharmacology 47(1): 41-44
Tibbitts, J.; Sambol, N.C.; Fike, J.R.; Bauer, W.F.; Kahl, S.B. 2000: Plasma pharmacokinetics and tissue biodistribution of boron following administration of a boronated porphyrin in dogs. Journal of Pharmaceutical Sciences 89(4): 469-477
Egorin, M.J.; Zuhowski, E.G.; Sentz, D.L.; Dobson, J.M.; Callery, P.S.; Eiseman, J.L. 1999: Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent. Cancer ChemoTherapy and Pharmacology 44(4): 283-294
Egorin, M.J.; Zuhowski, E.G.; Rosen, D.M.; Sentz, D.L.; Covey, J.M.; Eiseman, J.L. 2001: Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1. Cancer ChemoTherapy and Pharmacology 47(4): 291-302
Pai, M.P.; Bordley, J.; Amsden, G.W. 2001: Plasma pharmacokinetics and tissue penetration of alatrofloxacin in morbidly obese individuals. Clinical Drug Investigation 21(3): 219-224
Stinson, S.F.; House, T.; Bramhall, C.; Saavedra, J.E.; Keefer, L.K.; Nims, R.W. 2002: Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouse. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 32(4): 339-347
Egorin, M.J.; Yuan, Z.M.; Sentz, D.L.; Plaisance, K.; Eiseman, J.L. 1999: Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer ChemoTherapy and Pharmacology 43(6): 445-453
Eksborg, S.; Söderhäll, S.; Frostvik-Stolt, M.; Lindberg, A.; Liliemark, E. 2000: Plasma pharmacokinetics of etoposide (VP-16) after i.v. administration to children. Anti-Cancer Drugs 11(4): 237-241
Reinholz, M.M.; Haggard, J.J.; Curran, G.L.; Poduslo, J.F. 1999: Plasma pharmacokinetics, nervous system biodistribution and biostability, and spinal cord permeability at the blood-brain barrier of putrescine-modified catalase in the adult rat. Experimental Neurology 159(1): 191-203
Artuch, R.; Colomé, C.; Vilaseca, M.A.; Sierra, C.; Cambra, F.J.; Lambruschini, N.; Campistol, J. 2001: Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria. Journal of Inherited Metabolic Disease 24(3): 359-366
Baggio, B.; Budakovic, A.; Nassuato, M.A.; Vezzoli, G.; Manzato, E.; Luisetto, G.; Zaninotto, M. 2000: Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney International 58(3): 1278-1284
Clemmesen, J.O.; Høy, C.E.; Jeppesen, P.B.; Ott, P. 2000: Plasma phospholipid fatty acid pattern in severe liver disease. Journal of Hepatology 32(3): 481-487
Young, T.K.; Gerrard, J.M.; O'Neil, J.D. 1999: Plasma phospholipid fatty acids in the central Canadian arctic: biocultural explanations for ethnic differences. American Journal of Physical Anthropology 109(1): 9-18
Tan, K.C.B.; Shiu, S.W.M.; Wong, Y. 2003: Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus. European Journal of Clinical Investigation 33(4): 301-306
Cheung, M.C.; Wolfbauer, G.; Kennedy, H.; Brown, B.G.; Albers, J.J. 2001: Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin. Biochimica et Biophysica Acta 1537(2): 117-124
Riemens, S.C.; van Tol, A.; Sluiter, W.J.; Dullaart, R.P. 1999: Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes 48(8): 1631-1637
Desrumaux, C.; Deckert, V.; Athias, A.; Masson, D.; Lizard, G.; Palleau, V.; Gambert, P.; Lagrost, L. 1999: Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering alpha-tocopherol to endothelial cells. FASEB Journal 13(8): 883-892
Yeo, Y.K.; Kim, J.S.; Lee, J.R.; Lee, J.Y.; Chung, S.W.; Kim, H.J.; Horrocks, L.A.; Park, Y.S. 2000: Plasma phospholipids, including plasmalogens, after consumption of diets enriched in long-chain n-3 fatty acids. Journal of Biochemistry and Molecular Biology 33(6): 499-505
Tjoa, M.L.; van Vugt, J.M.; Mulders, M.A.; Schutgens, R.B.; Oudejans, C.B.; van Wijk, I.J. 2001: Plasma placenta growth factor levels in midtrimester pregnancies. Obstetrics and Gynecology 98(4): 600-607
Jinnin, M.; Ihn, H.; Yamane, K.; Asano, Y.; Yazawa, N.; Tamaki, K. 2003: Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension. Rheumatology 42(2): 240-243
Khovidhunkit, W.; Memon, R.A.; Shigenaga, J.K.; Pang, M.; Schambelan, M.; Mulligan, K.; Feingold, K.R.; Grunfeld, C. 1999: Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism, Clinical and Experimental 48(12): 1524-1531
Shohet, R.V.; Anwar, A.; Johnston, J.M.; Cohen, J.C. 1999: Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis. American Journal of Cardiology 83(1): 109-11 A8-9
Satoh, N.; Asano, K.; Naoki, K.; Fukunaga, K.; Iwata, M.; Kanazawa, M.; Yamaguchi, K. 1999: Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. American Journal of Respiratory and Critical Care Medicine 159(3): 974-979
Unno, N.; Nakamura, T.; Kaneko, H.; Uchiyama, T.; Yamamoto, N.; Sugatani, J.; Miwa, M.; Nakamura, S. 2000: Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan. Journal of Vascular Surgery 32(2): 263-267
Akisü, M.; Kültürsay, N.; Coker, I.; Hüseyinov, A. 1998: Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: Is it an additional marker of perinatal asphyxia?. Acta Paediatrica Japonica: Overseas Edition 40(5): 427-431
Mutlu, M.; Caner, H. 2000: Plasma polymerisation technique to overcome cerebrospinal fluid shunt infections. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 65(3A): 271-274
Pan, Y.V.; Wesley, R.A.; Luginbuhl, R.; Denton, D.D.; Ratner, B.D. 2001: Plasma polymerized N-isopropylacrylamide: synthesis and characterization of a smart thermally responsive coating. Biomacromolecules 2(1): 32-36
Hiratsuka, A.; Karube, I. 2000: Plasma polymerized films for sensor devices. Electroanalysis 12(9): 695-702
Hindmarsh, J.T.; Oliveras, L.; Greenway, D.C. 1999: Plasma porphyrins in the porphyrias. Clinical Chemistry 45(7): 1070-1076
Jaffa, A.A.; Durazo-Arvizu, R.; Zheng, D.; Lackland, D.T.; Srikanth, S.; Garvey, W.T.; Schmaier, A.H. 2003: Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes 52(5): 1215-1221
Cousins, C.M.; Holownia, P.; Hawkes, J.J.; Limaye, M.S.; Price, C.P.; Keay, P.J.; Coakley, W.T. 2000: Plasma preparation from whole blood using ultrasound. Ultrasound in Medicine and Biology 26(5): 881-888
Gøtze, J.P.; Kastrup, J. 2001: Plasma pro-brain natriuretic peptides are strong biochemical markers in clinical cardiology. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum 234: 47-51
Melander, O.; Frandsen, E.; Groop, L.; Hulthén, U.L. 2002: Plasma ProANP(1-30) reflects salt sensitivity in subjects with heredity for hypertension. Hypertension 39(5): 996-999
Yukioka, H.; Yoshida, G.; Kurita, S.; Kato, N. 2001: Plasma procalcitonin in sepsis and organ failure. Annals of the Academy of Medicine Singapore 30(5): 528-531
Silveira, A.; Schatteman, K.; Goossens, F.; Moor, E.; Scharpé, S.; Strömqvist, M.; Hendriks, D.; Hamsten, A. 2000: Plasma procarboxypeptidase U in men with symptomatic coronary artery disease. Thrombosis and Haemostasis 84(3): 364-368
Parissis, J.T.; Korovesis, S.; Giazitzoglou, E.; Kalivas, P.; Katritsis, D. 2002: Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. International Journal of Cardiology 83(1): 13-21
Ake Lopez, J.R.; Alfaro Gamboa, M.E.; Aguayo Arceo, A.M.; Holy, L. 1999: Plasma progesterone concentrations and embryo yield in superovulated cows under tropical conditions in the state of Yucatan in Mexico. Veterinaria - Mexico 30(1): 19-24
Shanbhag, B.A.; Radder, R.S.; Saidapur, S.K. 2001: Plasma progesterone levels and luteal activity during gestation and prolonged oviductal egg retention in a tropical lizard, Calotes versicolor. General and Comparative Endocrinology 123(1): 73-79
Kudoh, A.; Katagai, H.; Takazawa, T.; Matsuki, A. 2001: Plasma proinflammatory cytokine response to surgical stress in elderly patients. Cytokine 15(5): 270-273
Stattin, P.; Rinaldi, S.; Stenman, U.H.; Riboli, E.; Hallmans, G.; Bergh, A.; Kaaks, R. 2001: Plasma prolactin and prostate cancer risk: A prospective study. International Journal of Cancer 92(3): 463-465
Hankinson, S.E.; Willett, W.C.; Michaud, D.S.; Manson, J.E.; Colditz, G.A.; Longcope, C.; Rosner, B.; Speizer, F.E. 1999: Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 91(7): 629-634
Campino, C.; Torres, C.; Rioseco, A.; Poblete, A.; Pugin, E.; Valdés, V.; Catalán, S.; Belmar, C.; Serón-Ferré, M. 2001: Plasma prolactin/oestradiol ratio at 38 weeks gestation predicts the duration of lactational amenorrhoea. Human Reproduction 16(12): 2540-2545
Yoshitani, K.; Kawaguchi, M.; Takahashi, M.; Kitaguchi, K.; Furuya, H. 2003: Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass. British Journal of Anaesthesia 90(2): 122-126
Chiarelli, F.; Pomilio, M.; De Luca, F.A.; Vecchiet, J.; Verrotti, A. 2001: Plasma prorenin levels may predict persistent microalbuminuria in children with diabetes. Pediatric Nephrology 16(2): 116-120
Lavabre-Bertrand, T.; Henry, L.; Carillo, S.; Guiraud, I.; Ouali, A.; Dutaud, D.; Aubry, L.; Rossi, J.F.; Bureau, J.P. 2001: Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies. Cancer 92(10): 2493-2500
Lück, M.; Pistel, K.F.; Li, Y.X.; Blunk, T.; Müller, R.H.; Kissel, T. 1998: Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. Journal of Controlled Release: Official Journal of the Controlled Release Society 55(2-3): 107-120
Rosengren, A.; Pavlovic, E.; Oscarsson, S.; Krajewski, A.; Ravaglioli, A.; Piancastelli, A. 2002: Plasma protein adsorption pattern on characterized ceramic biomaterials. Biomaterials 23(4): 1237-1247
Schmidt, S.; Müller, R.H. 2003: Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions. International Journal of Pharmaceutics 254(1): 3-5
Procyshyn, R.M.; Kennedy, N.B.; Marriage, S.; Wasan, K.M. 2001: Plasma protein and lipoprotein distribution of clozapine. American Journal of Psychiatry 158(6): 949-951
Cofrades, S.G.erra, M.; Carballo, J.F.rnandez-Martin, F.J.menez-Colmenero, F. 2000: Plasma protein and soy fiber content effect on bologna sausage properties as influenced by fat level. Journal of food science 65(2): 281-287
Ono, M.; Arano, Y.; Mukai, T.; Uehara, T.; Fujioka, Y.; Ogawa, K.; Namba, S.; Nakayama, M.; Saga, T.; Konishi, J.; Horiuchi, K.; Yokoyama, A.; Saji, H. 2001: Plasma protein binding of (99m)Tc-labeled hydrazino nicotinamide derivatized polypeptides and peptides. Nuclear Medicine and Biology 28(2): 155-164
Matsushima, H.; Kamimura, H.; Soeishi, Y.; Watanabe, T.; Higuchi, S.; Miyazaki, M. 1999: Plasma protein binding of tamsulosin hydrochloride in renal disease: role of alpha1-acid glycoprotein and possibility of binding interactions. European Journal of Clinical Pharmacology 55(6): 437-443
Shibukawa, A.; Ishizawa, N.; Kimura, T.; Sakamoto, Y.; Ogita, K.; Matsuo, Y.; Kuroda, Y.; Matayatsu, C.; Nakagawa, T.; Wainer, I.W. 2002: Plasma protein binding study of oxybutynin by high-performance frontal analysis. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 768(1): 177-188
Wasan, E.K.; Waterhouse, D.; Sivak, O.; Bally, M.B.; Klasa, R.J.; Wasan, K.M. 2002: Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells. International Journal of Pharmaceutics 241(1): 57-64
Petibois, C.; Cazorla, G.; Cassaigne, A.; Déléris, G. 2001: Plasma protein contents determined by Fourier-transform infrared spectrometry. Clinical Chemistry 47(4): 730-738
Ahlqvist, J. 2003: Plasma protein osmotic pressure equations for humans. Journal of Applied Physiology 94(3): 1288-9; Discussion 1289
De, C.R.; Rocca, B.; Marchioli, R.; Landolfi, R. 2002: Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects. Thrombosis and Haemostasis 87(1): 58-67
Flerov, M.A.; Smirnova, N.N.; Svetlova, Z.V. 2003: Plasma protein peroxidation in patients with type 1 diabetes mellitus. Problemy Endokrinologii 49(4): 3-4
Gupta, R.; Kalia, M. 1998: Plasma protein status of expectant mothers of Palampur, Himachal Pradesh. Journal of Human Ecology 9(4): 393-395
Himmelfarb, J.; McMonagle, E.; McMenamin, E. 2000: Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney International 58(6): 2571-2578
Perna, A.F.; Castaldo, P.; De Santo, N.G.; di Carlo, E.; Cimmino, A.; Galletti, P.; Zappia, V.; Ingrosso, D. 2001: Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism. Kidney International 59(6): 2299-2308
Yokoyama, K.; Tajima, M.; Yoshida, H.; Nakayama, M.; Tokutome, G.; Sakagami, H.; Hosoya, T. 2002: Plasma pteridine concentrations in patients with chronic renal failure. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 17(6): 1032-1036
Klejewski, A.; Szcześniak-Chmielecka, A.; Zeromska-Cancellaro, M.; Urbaniak, T. 2000: Plasma purine turnover metabolites in women with normal pregnancy and pregnancy complicated with induced hypertension as compared to fetal well-being indices. Journal of Perinatal Medicine 28(5): 399-406
Nema, S.K.; Ganeshprasad, K.S. 2002: Plasma pyrolysis of medical waste. Current Science 83(3): 271-278
Mastroiacovo, P.; Peluso, I.; Dante, D.; Martino, F.; Agolini, D.; Perla, F.M. 1999: Plasma red-ox status in beta-thalassemic subjects. Rivista di Scienza dell'Alimentazione 28(3): 271-275
Mastroiacovo, P.; Multari, G.; Peluso, I.; Carru, A. 1999: Plasma red-ox status in patients with a recent onset of type 1 diabetes. Rivista di Scienza dell'Alimentazione 28(2): 153-157
Yamauchi, T.; Kuno, T.; Kanmatsuse, K. 1999: Plasma refilling rate analysis during dialysis by on-line hematocrit monitoring. Nihon University Journal of Medicine 41(4): 229-238
Chen, W.; Srinivasan, S.R.; Berenson, G.S. 2001: Plasma renin activity and insulin resistance in African American and white children: The Bogalusa Heart Study. American Journal of Hypertension 14(3): 212-217
Blumenfeld, J.D.; Sealey, J.E.; Alderman, M.H.; Cohen, H.; Lappin, R.; Catanzaro, D.F.; Laragh, J.H. 2000: Plasma renin activity in the emergency department and its independent association with acute myocardial infarction. American Journal of Hypertension 13(8): 855-863
Deinum, J.; Tarnow, L.; van Gool, J.M.; de Bruin, R.A.; Derkx, F.H.; Schalekamp, M.A.; Parving, H.H. 1999: Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(8): 1904-1911
Postnikov, A.A.; Model, S.V.; Bozh'ev, A.A.; Atopkov, V.A.; Tsyba, N.N.; Galkin, I.V. 2002: Plasma replacement in the treatment of ischemic heart disease. Terapevticheskii Arkhiv 74(5): 73-77
Franklin, S.T.; Nonnecke, B.J.; Horst, R.L. 2001: Plasma retinoids and composition of blood mononuclear leukocyte populations in holstein calves orally supplemented with 13-cis-retinoic acid. Journal of Nutritional Immunology 5(3-4): 115-130
Sirivichayakul, C.; Changbumrung, S.; Chanthavanich, P.; Moungnoi, P.; Chokejindachai, W.; Attanath, P.; Pengsaa, K. 2001: Plasma retinol and alpha-tocopherol level and growth indices of 7 months old healthy Thai infants in Bangkok. Southeast Asian Journal of Tropical Medicine and Public Health 32(2): 408-412
Newcomer, M.E.; Ong, D.E. 2000: Plasma retinol binding protein: Structure and function of the prototypic lipocalin. Biochimica et Biophysica Acta 1482(1-2): 57-64
Sánchez, M.; Azofra, J.; Anitua, E.; Andía, I.; Padilla, S.; Santisteban, J.; Mujika, Iñigo. 2003: Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Medicine and Science in Sports and Exercise 35(10): 1648-1652
Hori, Y.; Wada, H.; Mori, Y.; Shimura, M.; Hiyoyama, K.; Nakasaki, T.; Nishii, K.; Tamaki, S.; Nishikawa, M.; Deguchi, K.; Minami, N.; Shiku, H. 1999: Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation. American Journal of Hematology 61(1): 21-25
Grimsgaard, S.; Bonaa, K.H.; Jacobsen, B.K.; Bjerve, K.S. 1999: Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension 34(3): 478-483
Liu, S.L.; Hsieh, M.T.; Liu, C.H. 2000: Plasma scopoletin levels after a single dose oral administration in rabbits. Chinese Pharmaceutical Journal 52(4): 203-210
Sievers, E.; Arpe, T.; Schleyerbach, U.; Garbe-Schönberg, D.; Schaub, J. 2001: Plasma selenium in preterm and term infants during the first 12 months of life. Journal of Trace Elements in Medicine and Biology: Organ of the Society for Minerals and Trace Elements 14(4): 218-222
Yu, M.W.; Horng, I.S.; Hsu, K.H.; Chiang, Y.C.; Liaw, Y.F.; Chen, C.J. 1999: Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. American Journal of Epidemiology 150(4): 367-374
Boomsma, F.; de Kam, P.J.; Tjeerdsma, G.; van den Meiracker, A.H.; van Veldhuisen, D.J. 2000: Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure. European Heart Journal 21(22): 1859-1863
Boomsma, F.; Bhaggoe, U.M.; van der Houwen, A.M.B.; van den Meiracker, A.H. 2003: Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology. Biochimica et Biophysica Acta 1647(1-2): 48-54
Garpenstrand, H.; Ekblom, J.; von Arbin, M.; Oreland, L.; Murray, V. 1999: Plasma semicarbazide-sensitive amine oxidase in stroke. European Neurology 41(1): 20-23
Alvarez, J.C.; Gluck, N.; Fallet, A.; Grégoire, A.; Chevalier, J.F.; Advenier, C.; Spreux-Varoquaux, O. 1999: Plasma serotonin level after 1 day of fluoxetine treatment: A biological predictor for antidepressant response?. Psychopharmacology 143(1): 97-101
Paez, X.; Hernandez, L. 1998: Plasma serotonin monitoring by blood microdialysis coupled to high-performance liquid chromatography with electrochemical detection in humans. Journal of Chromatography B 720(1-2): 33-38
Vered, Y.; Spivak, B.; Nechmad, A.; Schlapnikov, N.; Graff, E.; Feinberg, I.; Gruper, D.; Weiss, M.; Kotler, M.; Weizman, A.; Mester, R. 2001: Plasma serotonin response to carbohydrate-rich food in chronic schizophrenic patients: clozapine versus classic antipsychotic agents. Human Psychopharmacology 16(5): 403-407
Yu, H.; Shu, X.-O.; Shi, R.; Dai, Q.; Jin, F.; Gao, Y.-T.; Li, B.D.L.; Zheng, W. 2003: Plasma sex steroid hormones and breast cancer risk in Chinese women. International Journal of Cancer 105(1): 92-97
Wu, E.B.; Lumb, P.; Chambers, J.B.; Crook, M.A. 1999: Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain. Atherosclerosis 145(2): 261-266
Gracheva, E.V.; Golovanova, N.K.; Ezhov, M.V.; Malyshev, P.P.; Kukharchuk, V.V.; Prokazova, N.V. 1999: Plasma sialyltransferase activity in healthy subjects and atherosclerotic patients. Biochemistry. Biokhimiia 64(11): 1315-1319
Greenleaf, J.E.; Hinghofer-Szalkay, H.; Rössler, A.; Farrell, P.A.; Loomis, J.L.; Fedele, M.J.; West, J.; Cowell, S.A.; Greenleaf, J.E. 2001: Plasma sodium-osmotic dissociation and hormonal interaction with drinking-induced hypervolemia at 2800 m altitude. Aviation Space and Environmental Medicine 72(6): 522-528
Ichikura, T.; Majima, T.; Uchida, T.; Okura, E.; Ogawa, T.; Mochizuki, H. 2001: Plasma soluble Fas ligand concentration: decrease in elderly men and increase in patients with gastric carcinoma. Oncology Reports 8(2): 311-314
John, S.; Jacobi, J.; Delles, C.; Schlaich, M.P.; Alter, O.; Schmieder, R.E. 2000: Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis. Clinical Science 98(5): 521-529
Güler, S.; Cakir, B.; Demirbas, B.; Yönem, A.; Odabasi, E.; Onde, U.; Aykut, O.; Gürsoy, Gül. 2002: Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy. Hormone Research 58(2): 67-70
Ogawa, H.; Yasue, H.; Miyao, Y.; Sakamoto, T.; Soejima, H.; Nishiyama, K.; Kaikita, K.; Suefuji, H.; Misumi, K.; Takazoe, K.; Kugiyama, K.; Yoshimura, M. 1999: Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina. American Journal of Cardiology 83(1): 38-42
Bulló, M.; Garcia-Lorda, P.; Salas-Salvadó, J. 2002: Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. European Journal of Endocrinology 146(3): 325-331
Fernández-Real, J.M.; Gutierrez, C.; Vendrell, J.; Casamitjana, R.; Ricart, W. 2000: Plasma soluble tumor necrosis factor-alpha receptors circulate in proportion to leptin levels during the menstrual cycle in lean but not in obese women. European Journal of Endocrinology 143(2): 235-241
Törnhage, C.J.; Serenius, F.; Uvnäs-Moberg, K.; Lindberg, T. 1998: Plasma somatostatin and cholecystokinin levels in preterm infants during kangaroo care with and without nasogastric tube-feeding. Journal of Pediatric Endocrinology and Metabolism: Jpem 11(5): 645-651
Foy, C.J.; Ardill, J.; Filmore, D.; Lawson, J.T.; Passmore, A.P. 2001: Plasma somatostatin and gastrointestinal peptides in Alzheimer's disease and vascular dementia. Qjm: Monthly Journal of the Association of Physicians 94(11): 631-635
Jiang, X.C.; Paultre, F.; Pearson, T.A.; Reed, R.G.; Francis, C.K.; Lin, M.; Berglund, L.; Tall, A.R. 2000: Plasma sphingomyelin level as a risk factor for coronary artery disease. Arteriosclerosis Thrombosis and Vascular Biology 20(12): 2614-2618
Tsui, Y.C.; Doyle, C.; Clyne, T.W. 1998: Plasma sprayed hydroxyapatite coatings on titanium substrates. Part 1: Mechanical properties and residual stress levels. Biomaterials 19(22): 2015-2029
Tsui, Y.C.; Doyle, C.; Clyne, T.W. 1998: Plasma sprayed hydroxyapatite coatings on titanium substrates. Part 2: optimisation of coating properties. Biomaterials 19(22): 2031-2043
Liu, X.; Ding, C. 2002: Plasma sprayed wollastonite/TiO2 composite coatings on titanium alloys. Biomaterials 23(20): 4065-4077
Masquelier, M.; Tirzitis, G.; Peterson, C.O.; Pålsson, M.; Amolins, A.; Plotniece, M.; Plotniece, A.; Makarova, N.; Vitols, S.G. 2000: Plasma stability and cytotoxicity of lipophilic daunorubicin derivatives incorporated into low density lipoproteins. European Journal of Medicinal Chemistry 35(4): 429-438
Chen, M.D.; Sheu, W.H. 2001: Plasma status of selected minerals in hypertensive men with and without insulin resistance. Journal of Trace Elements in Medicine and Biology: Organ of the Society for Minerals and Trace Elements 14(4): 228-231
Guillette, L.J.; Woodward, A.R.; Crain, D.A.; Pickford, D.B.; Rooney, A.A.; Percival, H.F. 1999: Plasma steroid concentrations and male phallus size in juvenile alligators from seven Florida lakes. General and Comparative Endocrinology 116(3): 356-372
Heupel, M.R.; Whittier, J.M.; Bennett, M.B. 1999: Plasma steroid hormone profiles and reproductive biology of the epaulette shark, Hemiscyllium ocellatum. Journal of Experimental Zoology 284(5): 586-594
Jessop, T.S.; Limpus, C.J.; Whittier, J.M. 1999: Plasma steroid interactions during high-density green turtle nesting and associated disturbance. General and Comparative Endocrinology 115(1): 90-100
Jennings, D.H.; Moore, M.C.; Knapp, R.; Matthews, L.; Orchinik, M. 2000: Plasma steroid-binding globulin mediation of differences in stress reactivity in alternative male phenotypes in tree lizards, Urosaurus ornatus. General and Comparative Endocrinology 120(3): 289-299
Soriano, A.; Martínez, C.; García, F.; Plana, M.; Palou, E.; Lejeune, Mène.; Aróstegui, J.I.; De Lazzari, E.; Rodriguez, C.; Barrasa, A.; Lorenzo, Jé.I.; Alcamí, Jé.; del Romero, J.; Miró, Jé.M.; Gatell, Jé.M.; Gallart, T. 2002: Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. Journal of Infectious Diseases 186(7): 922-931
Mohyi, D.L.; Kerdelhué, B.; Lenoir, V.; Kolm, P.; Jones, H.W.; Jones, G.S. 1998: Plasma substance-P and substance-K and gonadal steroids in relation to the gonadotropin surge in normal human reproductive cycles. Journal of Assisted Reproduction and Genetics 15(9): 547-551
Kobori, M.; Negishi, H.; Nagai, H.; Iyama, K. 2000: Plasma substitutes for volume replacement in hemorrhagic shock: Comparison of low and medium molecular weight hydroxyethyl starch. Current Therapeutic Research 61(7): 414-421
Ickx, B.E.; Bepperling, F.; Melot, C.; Schulman, C.; Van der Linden, P.J. 2003: Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. British Journal of Anaesthesia 91(2): 196-202
Brunetti, M.; Terracina, L.; Timio, M.; Saronio, P.; Capodicasa, E. 2001: Plasma sulfate concentration and hyperhomocysteinemia in hemodialysis patients. Journal of Nephrology 14(1): 27-31
Wang, S.Z.; Doyle, I.R.; Nicholas, T.E.; Forsyth, K.D. 1999: Plasma surfactant protein-B is elevated in infants with respiratory syncytial virus-induced bronchiolitis. Pediatric Research 46(6): 731-734
Laine, K.; Palovaara, S.; Tapanainen, P.; Manninen, P. 1999: Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy. Clinical Pharmacology and Therapeutics 66(6): 602-608
Maestu, J.; Jurimae, J.; Jurimae, T. 2002: Plasma testosterone and cortisol responses to maximal 2000 metre rowing ergometer test in highly trained male rowers. Medicina dello Sport 55(2): 89-93
Jürimäe, J.; Jürimäe, T.; Purge, P. 2001: Plasma testosterone and cortisol responses to prolonged sculling in male competitive rowers. Journal of Sports Sciences 19(11): 893-898
Blanco, C.; Ibáñez, A.; Blanco-Jerez, C.R.; Baca-Garcia, E.; Sáiz-Ruiz, J. 2001: Plasma testosterone and pathological gambling. Psychiatry Research 105(1-2): 117-121
Serrano, A. 2001: Plasma testosterone concentrations in captive male harp seals (Pagophilus groenlandicus). Aquatic Mammals 27(1): 50-55
Spivak, B.; Maayan, R.; Mester, R.; Weizman, A. 2003: Plasma testosterone levels in patients with combat-related posttraumatic stress disorder. Neuropsychobiology 47(2): 57-60
Kopeikina, L.T.; Kamper, E.F.; Mantas, A.; Kremastinos, D.; Stavridis, J.C. 1998: Plasma tetranectin levels in patients with unstable and stable angina. Fibrinolysis and Proteolysis 12(6): 353-359
Deschênes, G.; Veyradier, A.ès.; Cloarec, S.; Benoit, S.ép.; Desbois, I.; Gruel, Y.; Nivet, H. 2002: Plasma therapy in von Willebrand factor protease deficiency. Pediatric Nephrology 17(10): 867-870
Raijmakers, M.T.; Zusterzeel, P.L.; Steegers, E.A.; Hectors, M.P.; Demacker, P.N.; Peters, W.H. 2000: Plasma thiol status in preeclampsia. Obstetrics and Gynecology 95(2): 180-184
Vrbíková, J.; Tallová, J.; Biciková, M.; Dvoráková, K.; Hill, M.; Stárka, L. 2003: Plasma thiols and androgen levels in polycystic ovary syndrome. Clinical Chemistry and Laboratory Medicine 41(2): 216-221
Juhan-Vague, I.; Morange, P.E.; Aubert, H.; Henry, M.; Aillaud, M.F.; Alessi, M.C.; Samnegård, A.; Hawe, E.; Yudkin, J.; Margaglione, M.; Di Minno, G.; Hamsten, A.; Humphries, S.E. 2002: Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arteriosclerosis Thrombosis and Vascular Biology 22(5): 867-873
Inaba, Y.; Ichikawa, M.; Inoue, A.; Itoh, M.; Kyogashima, M.; Sekiguchi, Y.; Nakamura, S.; Komiyama, A.; Koh, C. 2001: Plasma thrombin-antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis. Journal of the Neurological Sciences 185(2): 89-93
Vayá, A.; Martínez, M.; Dalmau, J.; Martí, R.; Ballesta, A.; Aznar, J. 1998: Plasma thrombomodulin is not increased in familial hypercholesterolemic children with rheological alterations. Clinical Hemorheology and Microcirculation 19(2): 133-138
Yoshijima, S.; Kojima, T.; Sasai, M.; Hattori, K.; Taniuchi, S.; Kobayashi, Y. 2001: Plasma thrombomodulin levels in children with atopic dermatitis. Acta Paediatrica 90(2): 130-132
Yilmaz, T.; Akman, M.; Tutluoğlu, B.; Afrasyap, L.; Göylüsün, V.; Celik, N. 1999: Plasma thrombomodulin levels in lung cancer patients. Panminerva Medica 41(2): 125-128
Tamura, H.; Ogata, K.; Luo, S.; Nakamura, K.; Yokose, N.; Dan, K.; Tohyama, K.; Yoshida, Y.; Hamaguchi, H.; Sakamaki, H.; Kuwaki, T.; Tahara, T.; Kato, T.; Nomura, T. 1998: Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes. British Journal of Haematology 103(3): 778-784
Sola, M.C.; Calhoun, D.A.; Hutson, A.D.; Christensen, R.D. 1999: Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. British Journal of Haematology 104(1): 90-92
Göker, H.; Egesel, Türker.; Karakuş, S.; Haznedaroglu, I.C.; Apraş, S.; Büyükaşic, Y.; Sayinalp, Nün.; Ozcebe, O.I.; Dundar, S.; Kirazli, S.; Bayraktar, Y. 2002: Plasma thrombopoietin in patients with cavernous transformation of the portal vein. International Journal of Hematology 75(1): 91-94
Stockelberg, D.; Andersson, P.; Björnsson, E.; Björk, S.; Wadenvik, H. 1999: Plasma thrombopoietin levels in liver cirrhosis and kidney failure. Journal of Internal Medicine 246(5): 471-475
Gu, J.; Lu, L.; Xu, R.; Chen, X. 2002: Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura. Chinese Medical Journal 115(7): 983-986
Gurbel, P.A.; Murugesan, S.R.; Lowry, D.R.; Serebruany, V.L. 1999: Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction. Prostaglandins Leukotrienes and Essential Fatty Acids 61(1): 7-11
Burger, M.F.; Denver, R.J. 2002: Plasma thyroid hormone concentrations in a wintering passerine bird: their relationship to geographic variation, environmental factors, metabolic rate, and body fat. Physiological and Biochemical Zoology: Pbz 75(2): 187-199
Konings, C.H.; van Trotsenburg, A.S.; Ris-Stalpers, C.; Vulsma, T.; Wiedijk, B.M.; de Vijlder, J.J. 2001: Plasma thyrotropin bioactivity in Down's syndrome children with subclinical hypothyroidism. European Journal of Endocrinology 144(1): 1-4
Soejima, H.; Ogawa, H.; Yasue, H.; Nishiyama, K.; Kaikita, K.; Misumi, K.; Takazoe, K.; Kugiyama, K.; Tsuji, I.; Kumeda, K.; Nakamura, S. 1999: Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris. Thrombosis Research 93(1): 17-25
Timms, P.Mclean.; Wright, A.; Maxwell, P.; Campbell, S.; Dawnay, A.Beatrice.; Srikanthan, V. 2002: Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy. American Journal of Hypertension 15(3): 269-272
Ganti, A.Kishor.; Potti, A.; Yegnanarayan, R. 2002: Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction. Pathophysiology of Haemostasis and Thrombosis 32(2): 80-84
Fernández-Real, J.M.; Grasa, M.; Casamitjana, R.; Pugeat, M.; Barret, C.; Ricart, W. 1999: Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion. Journal of Clinical Endocrinology and Metabolism 84(9): 3192-3196
Gerardi, G.; Usberti, M.; Martini, G.; Albertini, A.; Sugherini, L.; Pompella, A.; Di, L.D. 2002: Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clinical Chemistry and Laboratory Medicine 40(2): 104-110
Hibbeln, J.R.; Umhau, J.C.; George, D.T.; Shoaf, S.E.; Linnoila, M.; Salem, N. 2000: Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acids. American Journal of Clinical Nutrition 71(1 Suppl): 331s-338s
Tan, Z.Sy.; Seshadri, S.; Beiser, A.; Wilson, P.W.F.; Kiel, D.P.; Tocco, M.; D'Agostino, R.B.; Wolf, P.A. 2003: Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Archives of Internal Medicine 163(9): 1053-1057
El-Khairy, L.; Ueland, P.M.; Refsum, H.; Graham, I.M.; Vollset, S.E. 2001: Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action project. Circulation 103(21): 2544-2549
El-Khairy, L.; Vollset, S.E.; Refsum, H.; Ueland, P.M. 2003: Plasma total cysteine, mortality, and cardiovascular disease hospitalizations: the Hordaland Homocysteine Study. Clinical Chemistry 49(6 Pt 1): 895-900
Ono, H.; Sakamoto, A.; Sakura, N. 2000: Plasma total glutathione concentrations in epileptic patients taking anticonvulsants. Clinica Chimica Acta; International Journal of Clinical Chemistry 298(1-2): 135-143
Ono, H.; Sakamoto, A.; Sakura, N. 2001: Plasma total glutathione concentrations in healthy pediatric and adult subjects. Clinica Chimica Acta; International Journal of Clinical Chemistry 312(1-2): 227-229
Wollesen, F.; Brattström, L.; Refsum, H.; Ueland, P.M.; Berglund, L.; Berne, C. 1999: Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney International 55(3): 1028-1035
Ozkan, Yşim.; Ozkan, E.; Simşek, B. 2002: Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. International Journal of Cardiology 82(3): 269-277
Shemin, D.; Lapane, K.L.; Bausserman, L.; Kanaan, E.; Kahn, S.; Dworkin, L.; Bostom, A.G. 1999: Plasma total homocysteine and hemodialysis access thrombosis: a prospective study. Journal of the American Society of Nephrology: Jasn 10(5): 1095-1099
Nurk, E.; Tell, G.S.; Vollset, S.Emil.; Nygård, O.; Refsum, H.; Ueland, P.M. 2002: Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study. Archives of Internal Medicine 162(12): 1374-1381
Caussé, E.; Malatray, P.; Calaf, R.; Charpiot, P.; Candito, M.; Bayle, C.; Valdiguié, P.; Salvayre, R.; Couderc, F. 2000: Plasma total homocysteine and other thiols analyzed by capillary electrophoresis/laser-induced fluorescence detection: comparison with two other methods. Electrophoresis 21(10): 2074-2079
Voutilainen, S.; Lakka, T.A.; Hämelahti, P.; Lehtimäki, T.; Poulsen, H.E.; Salonen, J.T. 2000: Plasma total homocysteine concentration and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Journal of Internal Medicine 248(3): 217-222
Arnadottir, M.; Hultberg, B.; Berg, A.L. 2001: Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 16(1): 45-47
Nedrebø, B.G.; Nygård, O.; Ueland, P.M.; Lien, E.A. 2001: Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. Clinical Chemistry 47(9): 1738-1741
Kanda, H. 2000: Plasma total homocysteine level in type 2 diabetic subjects: Association with insulin resistance and arterial intimal-medial thickness. Journal of the Osaka City Medical Center 49(1-2): 111-122
Retterstol, L.; Paus, B.; Bohn, M.; Bakken, A.; Erikssen, J.; Malinow, M.R.; Berg, K. 2003: Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study. Journal of Internal Medicine 253(3): 284-292
Bottiglieri, T.; Parnetti, L.; Arning, E.; Ortiz, T.; Amici, S.; Lanari, A.; Gallai, V. 2001: Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: A study in an Italian population with dementia. Mechanisms of Ageing and Development 122(16): 2013-2023
Lien, E.A.; Nedrebø, B.G.; Varhaug, J.E.; Nygård, O.; Aakvaag, A.; Ueland, P.M. 2000: Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. Journal of Clinical Endocrinology and Metabolism 85(3): 1049-1053
Nielsen, N.E.; Brattström, L.; Hultberg, B.; Landgren, F.; Swahn, E. 2000: Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease. Atherosclerosis 151(2): 423-431
Bar-On, H.; Kidron, M.; Friedlander, Y.; Ben-Yehuda, A.; Selhub, J.; Rosenberg, I.H.; Friedman, G. 2000: Plasma total homocysteine levels in subjects with hyperinsulinemia. Journal of Internal Medicine 247(2): 287-294
Martin, S.C.; Hilton, A.C.; Bartlett, W.A.; Jones, A.F. 1999: Plasma total homocysteine measurement by ion-paired reversed-phase HPLC with electrochemical detection. Biomedical Chromatography: Bmc 13(1): 81-82
Garcia, A.J.; Apitz-Castro, R. 2002: Plasma total homocysteine quantification: an improvement of the classical high-performance liquid chromatographic method with fluorescence detection of the thiol-SBD derivatives. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 779(2): 359-363
Vollset, S.E.; Refsum, H.; Irgens, L.M.; Emblem, B.M.; Tverdal, A.; Gjessing, H.K.; Monsen, A.L.; Ueland, P.M. 2000: Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. American Journal of Clinical Nutrition 71(4): 962-968
Fedler, C.; Stewart, M.J. 1999: Plasma total phenytoin: a possibly misleading test in developing countries. Therapeutic Drug Monitoring 21(2): 155-160
Carmel, R.; Brar, S.; Frouhar, Z. 2001: Plasma total transcobalamin I. Ethnic/racial patterns and comparison with lactoferrin. American Journal of Clinical Pathology 116(4): 576-580
Fiechtner, B.K.; Nuttall, G.A.; Johnson, M.E.; Dong, Y.; Sujirattanawimol, N.; Oliver, W.C.; Sarpal, R.S.; Oyen, L.J.; Ereth, M.H. 2001: Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesthesia and Analgesia 92(5): 1131-1136
Coupes, B.M.; Williams, S.; Roberts, I.S.; Short, C.D.; Brenchley, P.E. 2001: Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 16(2): 361-367
Kajdaniuk, D.; Marek, B.; Swietochowska, E.; Ostrowska, Z.; Glogowska-Szelag, J.; Kos-Kudla, B.; Ciesielska-Kopacz, N.; Wielkoszyski, T. 2000: Plasma transforming growth factor beta1 in breast cancer patients treated with CMF chemotherapy. Journal of Clinical Pharmacy and Therapeutics 25(4): 291-294
Duman, M.; Irken, Gülersu.; Oren, H.; Uçar, C.; Atabay, B.; Yilmaz, S.; Yüksel, F.; Ozkan, H. 2003: Plasma transforming growth factor beta1 levels in thrombocytopenic and nonthrombocytopenic neonates. Biology of the Neonate 84(3): 206-213
Hasegawa, T.; Yoneda, M.; Nakamura, K.; Makino, I.; Terano, A. 2001: Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Alimentary Pharmacology and Therapeutics 15(10): 1667-1672
Kong, F.; Jirtle, R.L.; Huang, D.H.; Clough, R.W.; Anscher, M.S. 1999: Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer 86(9): 1712-1719
Raila, J.; Mathews, U.; Schweigert, F.J. 2001: Plasma transport and tissue distribution of beta-carotene, vitamin A and retinol-binding protein in domestic cats. Comparative Biochemistry and Physiology. Part A Molecular and Integrative Physiology 130(4): 849-856
Schlaepfer, I.R.; Eckel, R.H. 1999: Plasma triglyceride reduction in mice after direct injections of muscle-specific lipoprotein lipase DNA. Diabetes 48(1): 223-227
Braun, S.L.; Barankay, A.; Mazzitelli, D. 2000: Plasma troponin T and troponin i after minimally invasive coronary bypass surgery. Clinical Chemistry 46(2): 279-281
Wingrove, J.; Bond, A.J.; Cleare, A.J.; Sherwood, R. 1999: Plasma tryptophan and trait aggression. Journal of Psychopharmacology 13(3): 235-237
Sheu WHH; Lee, W.J.; Chang, R.L.; Chen, Y.T. 2000: Plasma tumor necrosis factor alpha levels and insulin sensitivity in hypertensive subjects. Clinical and Experimental Hypertension 22(6): 595-606
Demirbaş, B.; Güler, S.; Cakir, B.; Culha, C.; Aral, Yçin. 2002: Plasma tumor necrosis factor-alpha levels and insulin resistance in nondiabetic hypertensive subjects. Hormone Research 58(6): 283-286
Skoog, T.; Dichtl, W.; Boquist, S.; Skoglund-Andersson, C.; Karpe, F.; Tang, R.; Bond, M.G.; de Faire, U.; Nilsson, J.; Eriksson, P.; Hamsten, A. 2002: Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. European Heart Journal 23(5): 376-383
Zikan, V.; Stepan, J.J. 2002: Plasma type 1 collagen cross-linked C-telopeptide: A sensitive marker of acute effects of salmon calcitonin on bone resorption. Clinica Chimica Acta 316(1-2): 63-69
Kontush, A.; Schippling, S.; Spranger, T.; Beisiegel, U. 1999: Plasma ubiquinol-10 as a marker for disease: is the assay worthwhile?. Biofactors 9(2-4): 225-229
Strauss, B.H.; Lau, H.K.; Bowman, K.A.; Sparkes, J.; Chisholm, R.J.; Garvey, M.B.; Fenkell, L.L.; Natarajan, M.K.; Singh, I.; Teitel, J.M. 1999: Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation 100(15): 1616-1622
Stephens, R.W.; Nielsen, H.J.; Christensen, I.J.; Thorlacius-Ussing, O.; Sørensen, S.; Danø, K.; Brünner, N. 1999: Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. Journal of the National Cancer Institute 91(10): 869-874
Richards, A.Mark.; Nicholls, M.Gary.; Lainchbury, J.G.; Fisher, S.; Yandle, T.G. 2002: Plasma urotensin II in heart failure. Lancet 360(9332): 545-546
Ng, L.L.; Loke, I.; O'Brien, R.J.; Squire, I.B.; Davies, J.E. 2002: Plasma urotensin in human systolic heart failure. Circulation 106(23): 2877-2880
Zeitler, P.; Schuster, V. 1999: Plasma values for u-PA in children. European Journal of Pediatrics 158(Suppl 3): S205-S208
Freedman, S.Benedict.; Vale, P.; Kalka, C.; Kearney, M.; Pieczek, A.; Symes, J.; Losordo, D.; Isner, J.M. 2002: Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA. Human Gene Therapy 13(13): 1595-1603
Blann, A.D.; Belgore, F.M.; Constans, J.; Conri, C.; Lip, G.Y. 2001: Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. American Journal of Cardiology 87(10): 1160-1163
Shimada, K.; Baba, T.; Neugebauer, S.; Onozaki, A.; Yamada, D.; Midorikawa, S.; Sato, W.; Watanabe, T. 2002: Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy. Journal of Diabetes and its Complications 16(6): 386-390
Maloney, J.; Wang, D.; Duncan, T.; Voelkel, N.; Ruoss, S. 2000: Plasma vascular endothelial growth factor in acute mountain sickness. Chest 118(1): 47-52
Lavie, L.; Kraiczi, H.; Hefetz, A.; Ghandour, H.; Perelman, A.; Hedner, J.; Lavie, P. 2002: Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. American Journal of Respiratory and Critical Care Medicine 165(12): 1624-1628
Wu, Y.; Saldana, L.; Chillar, R.; Vadgama, J.V. 2002: Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment. International Journal of Oncology 20(3): 509-516
Aguayo, A.; Kantarjian, H.M.; Estey, E.H.; Giles, F.J.; Verstovsek, S.; Manshouri, T.; Gidel, C.; O'Brien, S.; Keating, M.J.; Albitar, M. 2002: Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Cancer 95(9): 1923-1930
Lip, P.L.; Felmeden, D.C.; Blann, A.D.; Matheou, N.; Thakur, S.; Cunliffe, I.A.; Lip, G.Y.H. 2002: Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma. British Journal of Ophthalmology 86(11): 1299-1302
Uusimaa, P.; Ruskoaho, H.; Vuolteenaho, O.; Niemelä, M.; Lumme, J.; Ikäheimo, M.; Jounela, A.; Peuhkurinen, K. 1999: Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction. International Journal of Cardiology 69(1): 5-14
Shang Qianhui; Wang Pirong; Li Conghui 1998: Plasma vasoactive substances and cell cation transport in patients with essential hypertension. Zhonghua Xinxueguanbing Zazhi 26(5): 340-342
Kenefick, R.W.; Maresh, C.M.; Armstrong, L.E.; Castellani, J.W.; Riebe, D.; Echegaray, M.E.; Kavorous, S.A. 2000: Plasma vasopressin and aldosterone responses to oral and intravenous saline rehydration. Journal of Applied Physiology 89(6): 2117-2122
Devitt, H.; Holland, P.; Butler, R.; Redfern, E.; Hiley, E.; Roberts, G. 1999: Plasma vasopressin and response to treatment in primary nocturnal enuresis. Archives of Disease in Childhood 80(5): 448-451
Moser, A.B.; Kreiter, N.; Bezman, L.; Lu, S.; Raymond, G.V.; Naidu, S.; Moser, H.W. 1999: Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Annals of Neurology 45(1): 100-110
Childs, E.A.; Lyles, R.H.; Selnes, O.A.; Chen, B.; Miller, E.N.; Cohen, B.A.; Becker, J.T.; Mellors, J.; McArthur, J.C. 1999: Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52(3): 607-613
Rezza, G.; Lepri, A.C.; d'Arminio Monforte, A.; Pezzotti, P.; Castelli, F.; Dianzani, F.; Lazzarin, A.; De Luca, A.; Arlotti, M.; Leoncini, F.; Manconi, P.E.; Rizzardini, G.; Minoli, L.; Poggio, A.; Ippolito, G.; Phillips, A.N.; Moroni, M. 2000: Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group. Journal of Acquired Immune Deficiency Syndromes 25(1): 56-62
Andersson, S.; Norrgren, H.; da Silva, Z.; Biague, A.; Bamba, S.; Kwok, S.; Christopherson, C.; Biberfeld, G.; Albert, J. 2000: Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Archives of Internal Medicine 160(21): 3286-3293
Rolo Gomez, F.M.; Diaz Torres, H.M.; Blanco, D.A.mas, M.; Gessa Abreu, A.; Lubian Caballero, A.L.; Izquierdo Marquez, M. 2000: Plasma viral load levels in Cuban HIV-infected patients. Biotecnologia Aplicada 17(2): 99-101
Alabi, A.S.; Jaffar, S.; Ariyoshi, K.; Blanchard, T.; Schim van der Loeff, M.; Awasana, A.Aveika.; Corrah, T.; Sabally, S.; Sarge-Njie, R.; Cham-Jallow, F.; Jaye, A.; Berry, N.; Whittle, H. 2003: Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. Aids 17(10): 1513-1520
Tomiyama, Y.; Brian, J.E.; Todd, M.M. 2000: Plasma viscosity and cerebral blood flow. American Journal of Physiology. Heart and Circulatory Physiology 279(4): H1949-H1954
Carroll, S.; Cooke, C.B.; Butterly, R.J. 2000: Plasma viscosity and its biochemical predictors: associations with lifestyle factors in healthy middle-aged men. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 11(7): 609-616
Konukoglu, D.; Ercan, M.; Hatemi, H. 2002: Plasma viscosity in female patients with hypothyroidism: effects of oxidative stress and cholesterol. Clinical Hemorheology and Microcirculation 27(2): 107-113
Schott, G. 1998: Plasma viscosity in monoclonal gammapathies and their correlation to immunoglobulin and plasma protein levels. Onkologie 21(6): 492-495
Oviasu, E.; Famodu, A.A.; Ojeh, E.A. 1998: Plasma viscosity in nephrotic Nigerians. Clinical Hemorheology and Microcirculation 19(2): 163-167
Carroll, S.; Cooke, C.B.; Butterly, R.J. 2000: Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 11(1): 71-78
Lachili, B.; Faure, H.; Smail, A.; Zama, N.; Benlatreche, C.; Favier, A.; Roussel, A.M. 1999: Plasma vitamin A, E, and beta-carotene levels in adult post-partum Algerian women. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 69(4): 239-242
Bor, M.Vakur.; Refsum, H.; Bisp, M.R.; Bleie, Øyvind.; Schneede, J.; Nordrehaug, J.Erik.; Ueland, P.Magne.; Nygard, O.Kjell.; Nexø, E. 2003: Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: A randomized placebo-controlled study. Clinical Chemistry 49(1): 155-161
Polidori, M.C.; Mecocci, P.; Frei, B. 2001: Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke 32(4): 898-902
Kurl, S.; Tuomainen, T.P.; Laukkanen, J.A.; Nyyssönen, K.; Lakka, T.; Sivenius, J.; Salonen, J.T. 2002: Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 33(6): 1568-1573
Schindler, R.; Berndt, S.; Schroeder, P.; Oster, O.; Rave, G.; Sievers, H.-H. 2003: Plasma vitamin e and a changes during cardiopulmonary bypass and in the postoperative course. Langenbeck's Archives of Surgery 387(9-10): 372-378
Tebi, A.; Belbraouet, S.; Chau, N.; Debry, G. 2000: Plasma vitamin, beta-carotene, and alpha-tocopherol status according to age and disease in hospitalized elderly. Nutrition Research 20(10): 1395-1408
Schwaiger, J.; Negele, R.D. 1998: Plasma vitellogenin. A blood parameter to evaluate exposure of fish to xenoestrogens. Acta Veterinaria Brno 67(4): 257-264
Loeppky, J.A.; Luther, D.K.; Maes, D.; Riboni, K.; Hinghofer-Szalkay, H.; Charlton, G.A.; Icenogle, M.V. 2002: Plasma volume by Evans blue: effects of eating and comparison with other methods at altitude. Aviation Space and Environmental Medicine 73(9): 902-906
Jimenez, C.; Koulmann, N.; Savourey, G.; Launay, J.C.; Melin, B. 1998: Plasma volume changes after dehydration induced both by heat exposure and exercise, and glycerol hyperhydration. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1998(19): 107-108
Jimenez, C.; Melin, B.; Koulmann, N.; Allevard, A.M.; Launay, J.C.; Savourey, G. 1999: Plasma volume changes during and after acute variations of body hydration level in humans. European Journal of Applied Physiology and Occupational Physiology 80(1): 1-8
Jimenez, C.; Koulmann, N.; Guigas, B.; Bocqueraz, O.; Savourey, G.; Launay, J.C.; Melin, B. 1999: Plasma volume changes during prolonged exercise: Effect of the type of exercise (bycicle versus treadmill). Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1999(20): 157-158
Carranza, J.E.; Hahn, D.W. 2002: Plasma volume considerations for analysis of gaseous and aerosol samples using laser-induced breakdown spectroscopy. Journal of Analytical Atomic Spectrometry 17(11): 1534-1539
Brinch, K.; Møller, Søren.; Bendtsen, F.; Becker, U.; Henriksen, J.H. 2003: Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. Journal of Hepatology 39(1): 24-31
Bernstein, I.M.; Ziegler, W.; Badger, G.J. 2001: Plasma volume expansion in early pregnancy. Obstetrics and Gynecology 97(5 Pt 1): 669-672
Abu-Zidan, F.M.; Farrant, G.; Zwi, L.J.; Simovic, M.O.; Day, T.; Bonham, M.J.; Windsor, J.A. 1999: Plasma von Willebrand factor and intestinal ischaemia-reperfusion injury in rats. Thrombosis Research 94(6): 353-358
Conway, D.S.G.; Pearce, L.A.; Chin, B.S.P.; Hart, R.G.; Lip, G.Y.H. 2002: Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 106(15): 1962-1967
Li-Saw-Hee, F.L.; Blann, A.D.; Gurney, D.; Lip, G.Y. 2001: Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. European Heart Journal 22(18): 1741-1747
Haegele, A.D.; Gillette, C.; O'Neill, C.; Wolfe, P.; Heimendinger, J.; Sedlacek, S.; Thompson, H.J. 2000: Plasma xanthophyll carotenoids correlate inversely with indices of oxidative DNA damage and lipid peroxidation. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 9(4): 421-425
Aydemir, F.; Cavdar, A., O.; Soylemez, F. 2001: Plasma zinc and retinol binding protein concentrations in pregnant Turkish women: A longitudinal study. Journal of Trace Elements in Experimental Medicine 14(1): 11-16
Roungsipragarn, R.; Borirug, S.; Herabutya, Y. 1999: Plasma zinc level and intrauterine growth retardation: a study in pregnant women in Ramathibodi Hospital. Journal of the Medical Association of Thailand 82(2): 178-181
Aydemir, F.üs.; Cavdar, A.O.; Söylemez, F.; Cengiz, B. 2003: Plasma zinc levels during pregnancy and its relationship to maternal and neonatal characteristics: a longitudinal study. Biological Trace Element Research 91(3): 193-202
Hasskarl, H.; Ziegler, U. 2002: Plasma zur Fraktionierung: Wirkstoff oder Arzneimittel?. Infusion Therapy and Transfusion Medicine 29(4): 232-236
Ooi, A.; Ohkubo, T.; Higashigawa, M.; Kawasaki, H.; Kakito, H.; Kagawa, Y.; Kojima, M.; Sakurai, M. 2001: Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine. Biological and Pharmaceutical Bulletin 24(11): 1329-1331
Tokmak, F.; Schodjaian, K.; Musch, E.; Nguyen, S.Q.; Westermann, G.; Kosch, M.; Gerhardt, U.; Rahn, K.H.; Kisters, K. 2000: Plasma, intracellular and membrane magnesium concentrations and deficiency in cirrhosis of liver due to alcoholism. Trace Elements and Electrolytes 17(1): 4-7
Samyn, N.; De Boeck, G.; Wood, M.; Lamers, C.T.J.; De Waard, D.; Brookhuis, K.A.; Verstraete, A.G.; Riedel, W.J. 2002: Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Science International 128(1-2): 90-97
Zorbas, Y.G.; Kakurin, V.J.; Afonin, V.B.; Charapakhin, K.P.; Yarullin, V.L.; Deogenov, V.A. 2000: Plasma, urinary and fecal potassium changes in athletes during ambulatory, periodic, and continuous hypokinetic conditions. Clinical Biochemistry 33(1): 37-46
Tanaka, A.; Takahashi, Y.; Mizokuchi, M.; Shimada, N.; Koide, H. 1999: Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure. Renal Failure 21(5): 499-514
McKinney, E.T.; Shouri, R.; Hunt, R.S.; Ahokas, R.A.; Sibai, B.M. 2000: Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies. American Journal of Obstetrics and Gynecology 183(4): 874-877
Sampol, E.; Jacquet, A.; Viggiano, M.; Bernini, V.; Manelli, J.C.; Lacarelle, B.; Durand, A. 2000: Plasma, urine and skin pharmacokinetics of cefepime in burns patients. Journal of Antimicrobial ChemoTherapy 46(2): 315-317
Lerouge, S.; Guignot, C.; Tabrizian, M.; Ferrier, D.; Yagoubi, N.; Yahia, L. 2000: Plasma-based sterilization: Effect on surface and bulk properties and hydrolytic stability of reprocessed polyurethane electrophysiology catheters. Journal of Biomedical Materials Research 52(4): 774-782
Droste, C.; Hartmann, A.; Roskamm, H. 1999: Plasma-beta-endorphin and pathological hemodynamics in heart failure. Intensivmedizin und Notfallmedizin 36(3): 281-292
Onuoha, G.N.; Alpar, E.K. 2000: Plasma-circulating levels of natriuretic peptides in patients with bone and soft tissue injuries. Peptides 21(5): 617-621
Hendricks, S.K.; Kwok, C.; Shen, M.; Horbett, T.A.; Ratner, B.D.; Bryers, J.D. 2000: Plasma-deposited membranes for controlled release of antibiotic to prevent bacterial adhesion and biofilm formation. Journal of Biomedical Materials Research 50(2): 160-170
Mazzi, G.; Raineri, A.; Zucco, M.; Passadore, P.; Pomes, A.; Orazi, B.M. 1999: Plasma-exchange in chronic peripheral neurological disorders. International Journal of Artificial Organs 22(1): 40-46
Liu Tong; Song Zhimin; Shi Chuan; Yan Xuefeng 2000: Plasma-induced decomposition of nitrogen oxides in a dielectric-barrier discharge reactor. Huanjing Kexue 21(5): 80-82
Yamauchi, Y.kinori; Sugito, Masami; Kuzuya, Masayuki 1999: Plasma-induced free radicals of polycrystalline monocarbohydrates studied by electron spin resonance. Chemical and Pharmaceutical Bulletin 47(2): 273-278
Gupta, B.; Plummer, C.; Bisson, I.; Frey, P.; Hilborn, Jöns. 2002: Plasma-induced graft polymerization of acrylic acid onto poly(ethylene terephthalate) films: characterization and human smooth muscle cell growth on grafted films. Biomaterials 23(3): 863-871
Braulio, V.B.; Kouyoumdjian, M.; Zucoloto, S.; Figueiredo, F.; Borges, D.R. 1998: Plasma-kallikrein clearance during liver regeneration after partial hepatectomy in the rat. Liver 18(6): 371-377
Liang-Jinrui; Shen-Luhua; Yu-Junmin 1999: Plasma-lipid changes after acute myocardial infarction. Zhonghua Xinxueguanbing Zazhi 27(4): 280-282
Muguruma, H.; Karube, I. 1999: Plasma-polymerized films for biosensors. Trends in Analytical Chemistry 18(1): 62-68
Haddow, D.B.; Steele, D.A.; Short, R.D.; Dawson, R.A.; Macneil, S. 2003: Plasma-polymerized surfaces for culture of human keratinocytes and transfer of cells to an in vitro wound-bed model. Journal of Biomedical Materials Research. Part a 64(1): 80-87
Schorr, U.; Schultz, C.; Sharma, A.M. 2002: Plasma-renin response to isotonic volume contraction in young salt-sensitive normotensive men. American Journal of Hypertension 15(1 Pt 1): 48-52
Hanekom, W.A.; Hussey, G.D.; Hughes, E.J.; Potgieter, S.; Yogev, R.; Check, I.J. 1999: Plasma-soluble CD30 in childhood tuberculosis: effects of disease severity, nutritional status, and vitamin a therapy. Clinical and Diagnostic Laboratory Immunology 6(2): 204-208
Yoshimura, C.; Nomura, S.; Nagahama, M.; Ozaki, Y.; Kagawa, H.; Fukuhara, S. 2000: Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura. European Journal of Haematology 64(4): 219-224
Weng, J.; Wang, M.; Chen, J. 2002: Plasma-sprayed calcium phosphate particles with high bioactivity and their use in bioactive scaffolds. Biomaterials 23(13): 2623-2629
Ramires, P.A.; Mirenghi, L.; Romano, A.R.; Palumbo, F.; Nicolardi, G. 2000: Plasma-treated PET surfaces improve the biocompatibility of human endothelial cells. Journal of Biomedical Materials Research 51(3): 535-539
Chetty, R.; Hlatswayo, N.; Muc, R.; Sabaratnam, R.; Gatter, K. 2003: Plasmablastic lymphoma in HIV+ patients: An expanding spectrum. Histopathology 42(6): 605-609
Robak, T.; Urbanska-Rys, H.; Strzelecka, B.; Krykowski, E.; Bartkowiak, J.; Blonski, J.Z.; Kordek, R.; Warzocha, K. 2001: Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): An unusual variant of Richter's syndrome. European Journal of Haematology 67(5-6): 322-327
Lin, Y.; Rodrigues, G.D.; Turner, J.F.; Vasef, M.A. 2001: Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Archives of Pathology and Laboratory Medicine 125(2): 282-285
Borrero, J.J.; Pujol, E.; Pérez, Sía.; Merino, D.; Montaño, A.; Rodríguez, F.J. 2002: Plasmablastic lymphoma of the oral cavity and jaws. Aids 16(14): 1979-1980
Nguyen, D.D.; Loo, B.W.; Tillman, G.; Natkunam, Y.; Cao, T.M.; Vaughan, W.; Dorfman, R.F.; Goffinet, D.R.; Jacobs, C.D.; Advani, R.H. 2003: Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Annals of Hematology 82(8): 521-525
Rajkumar, S.V.; Fonseca, R.; Lacy, M.Q.; Witzig, T.E.; Therneau, T.M.; Kyle, R.A.; Litzow, M.R.; Gertz, M.A.; Greipp, P.R. 1999: Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(5): 1551-1557
Lee, C.Kwong.; Ma, E.S.K.; Shek, T.W.H.; Lam, C.C.K.; Au, W.Yan.; Wan, T.S.K.; Chan, L.Chong. 2003: Plasmablastic transformation of multiple myeloma. Human Pathology 34(7): 710-714
Lang, C.; Lukasewitz, P.; Wulf, H.; Geldner, G. 2002: Plasmacholinesterasevarianten als Ursache prolongierter neuromuskulaerer Blockaden. Uebersicht und Poblemdarstellung anhand zweier Fallberichte prolongierter neuromuskulaerer Blockaden nach Muskelrelaxation mit Succinylbischolin bzw.Mivacurium. Anaesthesist 51(2): 134-141
Kemp, T.J.; Elzey, B.D.; Griffith, T.S. 2003: Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation. Journal of Immunology 171(1): 212-218
Cella, M.; Facchetti, F.; Lanzavecchia, A.; Colonna, M. 2000: Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nature Immunology 1(4): 305-310
Patterson, S.; Rae, A.; Hockey, N.; Gilmour, J.; Gotch, F. 2001: Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. Journal of Virology 75(14): 6710-6713
Jego, G.; Palucka, A.Karolina.; Blanck, J-Philippe.; Chalouni, C.; Pascual, V.; Banchereau, J. 2003: Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19(2): 225-234
Salio, M.; Cella, M.; Vermi, W.; Facchetti, F.; Palmowski, M.J.; Smith, C.L.; Shepherd, D.; Colonna, M.; Cerundolo, V. 2003: Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. European Journal of Immunology 33(4): 1052-1062
Gibson, S.J.; Lindh, J.M.; Riter, T.R.; Gleason, R.M.; Rogers, L.M.; Fuller, A.E.; Oesterich, J.L.; Gorden, K.B.; Qiu, X.; McKane, S.W.; Noelle, R.J.; Miller, R.L.; Kedl, R.M.; Fitzgerald-Bocarsly, P.; Tomai, M.A.; Vasilakos, J.P. 2002: Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cellular Immunology 218(1-2): 74-86
Wollenberg, A.; Wagner, M.; Günther, S.; Towarowski, A.; Tuma, E.; Moderer, M.; Rothenfusser, S.; Wetzel, S.; Endres, S.; Hartmann, G. 2002: Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. Journal of Investigative Dermatology 119(5): 1096-1102
Rossi, M.; Arpinati, M.; Rondelli, D.; Anasetti, C. 2002: Plasmacytoid dendritic cells: Do they have a role in immune responses after hematopoietic cell transplantation?. Human Immunology 63(12): 1194-1200
Dzionek, A.; Inagaki, Y.; Okawa, K.; Nagafune, J.; Röck, Jürgen.; Sohma, Y.; Winkels, G.; Zysk, M.; Yamaguchi, Y.; Schmitz, Jürgen. 2002: Plasmacytoid dendritic cells: From specific surface markers to specific cellular functions. Human Immunology 63(12): 1133-1148
John, M.; Mahlig, K.; Müller, G.M.; Fietze, I.; Witt, C. 1999: Plasmacytoid monocytes appear in the bronchoalveolar lavage: Differences between smokers and nonsmokers. Experimental Lung Research 25(2): 143-150
López, J.I.; Ugalde, A.; Arostegui, J.; Bilbao, F.J. 2000: Plasmacytoid myoepithelioma of the soft palate. Report of a case with cytologic, immunohistochemical and electron microscopic studies. Acta Cytologica 44(4): 647-652
Zhang, X-min.; Elhosseiny, A.; Melamed, M.R. 2002: Plasmacytoid urothelial carcinoma of the bladder. A case report and the first description of urinary cytology. Acta Cytologica 46(2): 412-416
Theodossiou, C.; Burroughs, R.; Wynn, R.; Schwarzenberger, P. 1998: Plasmacytoma in HIV disease: two case reports and review of the literature. American Journal of the Medical Sciences 316(5): 351-353
Cangiarella, J.; Waisman, J.; Cohen, J.M.; Chhieng, D.; Symmans, W.F.; Goldenberg, A. 2000: Plasmacytoma of the breast. A report of two cases diagnosed by aspiration biopsy. Acta Cytologica 44(1): 91-94
O'Neal, M.L.; Entel, R.J. 2002: Plasmacytoma of the cricoid cartilage with airway mass effect. Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties 64(5): 373-376
Saad, R.; Raab, S.; Liu, Y.; Pollice, P.; Silverman, J.F. 2001: Plasmacytoma of the larynx diagnosed by fine-needle aspiration cytology: A case report. Diagnostic Cytopathology 24(6): 408-411
Engelsma, R.J.; De Bree, R.; Janssen, J.J.; Scheeren, R.A. 2000: Plasmacytoma of the mastoid bone: solitary and systemic. Journal of Laryngology and Otology 114(5): 378-380
Emery, J.D.; Kennedy, A.W.; Tubbs, R.R.; Castellani, W.J.; Hussein, M.A. 1999: Plasmacytoma of the ovary: a case report and literature review. Gynecologic Oncology 73(1): 151-154
Röcken, C.; Hegenbarth, V.; Schmitz, M.; Stix, B.; Schade, G.; Mohnert, A.; Roessner, A. 2000: Plasmacytoma of the tonsil with AL amyloidosis: Evidence of post-fibrillogenic proteolysis of the fibril protein. Virchows Archiv: An International Journal of Pathology 436(4): 336-344
Lemos, N.; Melo, C.R.; Soares, I.C.; Lemos, R.R.; Lemos, F.R. 2000: Plasmacytoma of the urethra treated by excisional biopsy. Scandinavian Journal of Urology and Nephrology 34(1): 75-76
Shin, J.S.; Stopyra, G.A.; Warhol, M.J.; Multhaupt, H.A. 2001: Plasmacytoma with aberrant expression of myeloid markers, T-cell markers, and cytokeratin. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 49(6): 791-792
Farinola, M.A.; Lawler, L.P.; Rosenthal, D. 2003: Plasmacytoma with involvement of the urinary bladder. Report of a case diagnosed by urine cytology. Acta Cytologica 47(5): 787-791
Miller, F.R.; Lavertu, P.; Wanamaker, J.R.; Bonafede, J.; Wood, B.G. 1998: Plasmacytomas of the head and neck. Otolaryngology - Head and Neck Surgery 119(6): 614-618
Gogovska, L.; Ljapcev, R.; Polenakovic, M.; Stojkovski, L.; Popovska, M.; Grcevska, L. 2003: Plasmaexchange in the treatment of myasthenia gravis associated with thymoma. International Journal of Artificial Organs 26(2): 170-173
Cordoba Pedregosa, M.C.; Gonzalez Reyes, J.A.; Serrano, A.; Villalba, J.M.; Navas, P.; Cordoba, F. 1998: Plasmalemma-associated with malate dehydrogenase activity in onion root cells. Protoplasma 205(1-4): 29-36
Heming, T.A.; Bidani, A. 2002: Plasmalemmal H+ extruders in mammalian alveolar macrophages. Comparative Biochemistry and Physiology. Part A Molecular and Integrative Physiology 133(1): 143-150
Baumgartner, W.; Drenckhahn, D. 2002: Plasmalemmal concentration and affinity of mouse vascular endothelial cadherin, VE-cadherin. European Biophysics Journal: Ebj 31(7): 532-538
Bonen, A.; Benton, C.R.; Campbell, S.E.; Chabowski, A.; Clarke, D.C.; Han, X.-X.; Glatz, J.F.C.; Luiken, J.J.F.P. 2003: Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes. Acta Physiologica Scandinavica 178(4): 347-356
Raghunand, N.; Altbach, M.I.; van Sluis, R.; Baggett, B.; Taylor, C.W.; Bhujwalla, Z.M.; Gillies, R.J. 1999: Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochemical Pharmacology 57(3): 309-312
Detrait, E.R.; Yoo, S.; Eddleman, C.S.; Fukuda, M.; Bittner, G.D.; Fishman, H.M. 2000: Plasmalemmal repair of severed neurites of PC12 cells requires Ca(2+) and synaptotagmin. Journal of Neuroscience Research 62(4): 566-573
Rasgado-Flores, H.; Gonzalez-Serratos, H. 2000: Plasmalemmal transport of magnesium in excitable cells. Frontiers in Bioscience: a Journal and Virtual Library 5: D866-D879
Stoeckel, H.; Takeda, K. 2002: Plasmalemmal voltage-activated K(+) currents in protoplasts from tobacco BY-2 cells: possible regulation by actin microfilaments?. Protoplasma 220(1-2): 79-87
Styger, R.; Wiesmann, U.N.; Honegger, U.E. 2002: Plasmalogen content and beta-adrenoceptor signalling in fibroblasts from patients with Zellweger syndrome. Effects of hexadecylglycerol. Biochimica et Biophysica Acta 1585(1): 39-43
Han, X.; Holtzman, D.M.; McKeel, D.W. 2001: Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: Molecular characterization using electrospray ionization mass spectrometry. Journal of Neurochemistry 77(4): 1168-1180
Stadelmann-Ingrand, S.; Favreliere, S.; Fauconneau, B.; Mauco, G.; Tallineau, C. 2001: Plasmalogen degradation by oxidative stress: production and disappearance of specific fatty aldehydes and fatty alpha-hydroxyaldehydes. Free Radical Biology and Medicine 31(10): 1263-1271
Brosche, T. 2001: Plasmalogen levels in serum from patients with impaired carbohydrate or lipid metabolism and in elderly subjects with normal metabolic values. Archives of Gerontology and Geriatrics 32(3): 283-294
Gaposchkin, D.P.; Zoeller, R.A. 1999: Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants. Journal of Lipid Research 40(3): 495-503
Zoeller, R.A.; Lake, A.C.; Nagan, N.; Gaposchkin, D.P.; Legner, M.A.; Lieberthal, W. 1999: Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. Biochemical Journal 338: 769-776
Toelle, A.; Meier, W.; Greune, G.; Ruediger, M.; Hofmann, K.P.; Ruestow, B. 1999: Plasmalogens reduce the viscosity of a surfactant-like phospholipid monolayer. Chemistry and Physics of Lipids 100(1-2): 81-87
Splendiani, G.; Cipriani, S.; Passalacqua, S.; Sturniolo, A.; Costanzi, S.; Fulignati, P.; Staffolani, E.; Casciani, C.U. 2003: Plasmaperfusion on triptophan columns can improve the clinical outcome of patients affected with Myasthenia Gravis. Artificial Cells Blood Substitutes and Immobilization Biotechnology 31(1): 69-79
Mori, M.; Kuwabara, S.; Fukutake, T.; Hattori, T. 2002: Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases. Journal of Neurology Neurosurgery and Psychiatry 72(5): 680
Kaminska, R.; Ikäheimo, R.; Hollmen, A. 1999: Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum. Clinical and Experimental Dermatology 24(2): 81-85
Grauhan, O.; Knosalla, C.; Ewert, R.; Hummel, M.; Loebe, M.; Weng, Y.G.; Hetzer, R. 2001: Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 20(3): 316-321
Khamidov, S., A.; Pakirdinov, A.B.; Kilichev, R.M. 2002: Plasmapheresis and hyperbaric oxygenation in the combined therapy of skin angiitis. Vestnik Dermatologii i Venerologii 1: 36-38
Hao, W.; Davis, C.; Hirsch, I.B.; Eng, L.J.; Daniels, T.; Walsh, D.; Lernmark, A. 1999: Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study. Journal of Neurology 246(8): 731-735
Montgomery, R.A.; Zachary, A.A.; Racusen, L.C.; Leffell, M.S.; King, K.E.; Burdick, J.; Maley, W.R.; Ratner, L.E. 2000: Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70(6): 887-895
Egan, C.A.; Meadows, K.P.; Zone, J.J. 2000: Plasmapheresis as a steroid saving procedure in bullous pemphigoid. International Journal of Dermatology 39(3): 230-235
Egan, C.A.; Grant, W.J.; Morris, S.E.; Saffle, J.R.; Zone, J.J. 1999: Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. Journal of the American Academy of Dermatology 40(3): 458-461
Yasumoto, Y.ichiro; Zhang, Yixiang; Tsukamoto, Masatoshi; Nishimoto, Kiichiro; Nozaki, Tsuyoshi; Harada, Kouji; Sogabe, Atsushi; Lin, Xiaoyan; Arima, Terukatsu 2003: Plasmapheresis by dextran sulfate increases primary cultured human mesangium proliferation. Medical Journal of Kagoshima University 55(1): 7-14
Kolker, O.; Sviri, S.; Linton, D.M.; Or, R.; Nagler, A.; Shapira, M.Y. 2001: Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation. Acta Haematologica 105(3): 156-158
Balestri, P.; Grosso, S.; Acquaviva, A.; Bernini, M. 2000: Plasmapheresis in a child affected by acute disseminated encephalomyelitis. Brain and Development 22(2): 123-126
Magen, D.; Oliven, A.; Shechter, Y.; Elhasid, R.; Bar-Joseph, G.; Zelikovic, I. 2001: Plasmapheresis in a very young infant with atypical hemolytic uremic syndrome. Pediatric Nephrology 16(1): 87-90
Kuhlmann, U.; Schoenemann, H.; Müller, T.; Keuchel, M.; Lange, H. 2000: Plasmapheresis in life-threatening verapamil intoxication. Artificial Cells Blood Substitutes and Immobilization Biotechnology 28(5): 429-440
Claus, D.; Specht, S.; Zieschang, M. 2000: Plasmapheresis in multifocal motor neuropathy: a case report. Journal of Neurology Neurosurgery and Psychiatry 68(4): 533-535
Yeh, J.H.; Chiu, H.C. 1999: Plasmapheresis in myasthenia gravis. A comparative study of daily versus alternately daily schedule. Acta Neurologica Scandinavica 99(3): 147-151
Potekaev, N.S.; Khaldin, A.A.; Shkrebets, S.V.; Potekaev, N.N.; Varlamova, E.Y. 1999: Plasmapheresis in the treatment of Arndt-Gottron scleromyxedema. Vestnik Dermatologii i Venerologii 1999(2): 18-20
Mukhamedov, N.B.; Inoyatova, F.I. 2002: Plasmapheresis in the treatment of chronic viral hepatitis B. Uzbekiston Tibbiet Zhurnali (2-3): 49-51
Ellingsen, I.; Florvaag, E.; Andreassen, A.H.; Iversen, B.M.; Irgens, A.; Matre, R. 2001: Plasmapheresis in the treatment of steroid-dependent bronchial asthma. Allergy 56(12): 1202-1205
Mazzi, G.; Raineri, A.; Zanolli, F.A.; Da Ponte, C.; De Roia, D.; Santarossa, L.; Guerra, R.; Orazi, B.M. 2003: Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 28(1): 13-18
Katsuno, M.; Sugita, Y.; Okano, E.; Tokura, H.; Nagatani, T.; Nakajima, H. 1999: Plasmapheresis treatment for bullous pemphigoid induces marked reduction of the serum IL-6 level rather than the titre of circulating autoantibodies. ActaDermato-Venereologica 79(4): 326
Greenstein, S.M.; Delrio, M.; Ong, E.; Feuerstein, D.; Schechner, R.; Kim, D.; Corey, H.; Kaskel, R.; Tellis, V.A.; Moritz, M.L. 2000: Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatric Nephrology 14(12): 1061-1065
Pisani, B.A.; Mullen, G.M.; Malinowska, K.; Lawless, C.E.; Mendez, J.; Silver, M.A.; Radvany, R.; Robinson, J.A. 1999: Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 18(7): 701-706
Kavuru, M.S.; Bonfield, T.L.; Thomassen, M.J. 2003: Plasmapheresis, GM-CSF, and alveolar proteinosis. American Journal of Respiratory and Critical Care Medicine 167(7): 1036; Author Reply 1036-7
Vécsei, A.K.; Müller, T.; Schratzberger, E.C.; Kircher, K.; Regele, H.; Arbeiter, K.; Schroth, B.; Aufricht, C. 2001: Plasmapheresis-induced remission in otherwise therapy-resistant FSGS. Pediatric Nephrology 16(11): 898-900
Yeh, J.H.; Chiu, H.C. 2000: Plasmapheresis-related hypotension. Artificial Organs 24(9): 705-709
Mandal, A.K.; King, K.E.; Humphreys, S.L.; Maley, W.R.; Burdick, J.F.; Klein, A.S. 2000: Plasmapheresis: an effective therapy for primary allograft nonfunction after liver transplantation. Transplantation 70(1): 216-220
Schwenger, V. 2001: Plasmaseparation bei Propafenonintoxikation. Intensivmedizin und Notfallmedizin 38(2): 124-127
D.M., S.M.; Pedroso, R.C. 1999: Plasmatic and urinary screening for drugs that cause depressive syndrome by capillary column gas chromatography. Revista Brasileira de Ciencias Farmaceuticas 35(2): 289-295
Agulló-Ortuño, M.T.; Albaladejo, M.D.; Parra, S.; Rodríguez-Manotas, M.; Fenollar, M.; Ruíz-Espejo, F.; Tebar, J.; Martínez, P. 2002: Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Clinica Chimica Acta; International Journal of Clinical Chemistry 326(1-2): 105-112
Chirico, A.; Herrera, D.; Esteban, L.; Cordini, M.L.; Font Nine, L.; Arch, A.; Soldano, L.; Kesckes, C. 1999: Plasmatic levels of calcium, phosphorus, magnesium and albumin in a group of patients admitted at a critical care unit. Relationship with a prognostic indicator of severity. Prensa Medica Argentina 86(5): 503-507
Correa, R.C.; Alfieri, A.B. 2003: Plasmatic nitric oxide, but not von Willebrand Factor, is an early marker of endothelial damage, in type 1 diabetes mellitus patients without microvascular complications. Journal of Diabetes and its Complications 17(5): 264-268
Nivcgab, E.A.; Loskutova, S.A.; Chuprova, A.V.; Telegina, T.A.; Suvorova, T.S.; Tov, N.L. 2003: Plasmic activity of phospholipid membranes in nephritis. Terapevticheskii Arkhiv 75(4): 40-44
Yasuda, K.; Ogawa, Y.; Kishimoto, M.; Takagi, T.; Hashida, M.; Takakura, Y. 2002: Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes. Biochemical and Biophysical Research Communications 293(1): 344-348
Ahmad, S.; Kitchin, K.T.; Cullen, W.R. 2002: Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. Toxicology Letters 133(1): 47-57
Hirosue, S.; Müller, B.G.; Mulligan, R.C.; Langer, R. 2001: Plasmid DNA encapsulation and release from solvent diffusion nanospheres. Journal of Controlled Release: Official Journal of the Controlled Release Society 70(1-2): 231-242
Wildbaum, G.; Netzer, N.; Karin, N. 2002: Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. Journal of Immunology 168(11): 5885-5892
Luo, Y.; O'Hagan, D.; Zhou, H.; Singh, M.; Ulmer, J.; Reisfeld, R.A.; James Primus, F.; Xiang, R. 2003: Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice. Vaccine 21(17-18): 1938-1947
Johnson, P.A.; Conway, M.A.; Daly, J.; Nicolson, C.; Robertson, J.; Mills, K.H. 2000: Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. Journal of General Virology 81(Part 7): 1737-1745
Miller, M.; Cho, J.Youn.; Baek, K.Je.; Castaneda, D.; Nayar, J.; Rodriguez, M.; Roman, M.; Raz, E.; Broide, D.H. 2002: Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness. Vaccine 20(23-24): 3023-3033
Kaur, R.; Sachdeva, G.; Vrati, S. 2002: Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. Journal of Infectious Diseases 185(1): 1-12
Uwiera, R.R.; Gerdts, V.; Pontarollo, R.A.; Babiuk, L.A.; Middleton, D.M.; Griebel, P.J. 2001: Plasmid DNA induces increased lymphocyte trafficking: a specific role for CpG motifs. Cellular Immunology 214(2): 155-164
Martin, T.; Parker, S.E.; Hedstrom, R.; Le, T.; Hoffman, S.L.; Norman, J.; Hobart, P.; Lew, D. 1999: Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection. Human Gene Therapy 10(5): 759-768
Parker, S.E.; Borellini, F.; Wenk, M.L.; Hobart, P.; Hoffman, S.L.; Hedstrom, R.; Le, T.; Norman, J.A. 1999: Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits. Human Gene Therapy 10(5): 741-758
Winters, M.A.; Richter, J.D.; Sagar, S.L.; Lee, A.L.; Lander, R.J. 2003: Plasmid DNA purification by selective calcium silicate adsorption of closely related impurities. Biotechnology Progress 19(2): 440-447
Kreiss, P.; Cameron, B.; Rangara, R.; Mailhe, P.; Aguerre-Charriol, O.; Airiau, M.; Scherman, D.; Crouzet, J.; Pitard, B. 1999: Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Research 27(19): 3792-3798
Q.D.; Ying Zhekang; Wang Wenyi 2000: Plasmid DNA switches on Th1 response in mice immunized with antigen-antibody complex. Zhonghua Weishengwuxue He Mianyixue Zazhi 20(4): 365-369
Hassett, D.E.; Zhang, J.; Whitton, J.L. 1999: Plasmid DNA vaccines are effective in the absence of IFNgamma. Virology 263(1): 175-183
Mor, G.; Eliza, M. 2001: Plasmid DNA vaccines. Immunology, tolerance, and autoimmunity. Molecular Biotechnology 19(3): 245-250
Cui, Z.; Mumper, R.J. 2002: Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: In vitro and in vivo evaluation. Bioconjugate Chemistry 13(6): 1319-1327
Higgins, T.J.; Herold, K.M.; Arnold, R.L.; McElhiney, S.P.; Shroff, K.E.; Pachuk, C.J. 2000: Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses. Journal of Infectious Diseases 182(5): 1311-1320
Musacchio, A.; Quintana, D.; Herrera, A.M.; Sandez, B.; Alvarez, J.C.; Falcón, V.; la Rosa, M.C.; Alvarez, F.; Pichardo, D. 2001: Plasmid DNA-recombinant Opc protein complexes for nasal DNA immunization. Vaccine 19(27): 3692-3699
Weiner, D. 2000: Plasmid interleukin 12. Aids 14(12): 1759-1760
Weitao, T.; Dasgupta, S.; Nordström, K. 2000: Plasmid R1 is present as clusters in the cells of Escherichia coli. Plasmid 43(3): 200-204
Hoffmann, F.; Rinas, U. 2001: Plasmid amplification in Escherichia coli after temperature upshift is impaired by induction of recombinant protein synthesis. Biotechnology Letters 23(22): 1819-1825
Gerdes, K.; Møller-Jensen, J.; Bugge Jensen, R. 2000: Plasmid and chromosome partitioning: Surprises from phylogeny. Molecular Microbiology 37(3): 455-466
Ahokas, H. 2002: Plasmid carrying bacteria from catkin galls of Salix caprea. Memoranda Societatis pro Fauna et Flora Fennica 78(2): 49-54
Barouch, D.H.; McKay, P.F.; Sumida, S.M.; Santra, S.; Jackson, S.S.; Gorgone, D.A.; Lifton, M.A.; Chakrabarti, B.K.; Xu, L.; Nabel, G.J.; Letvin, N.L. 2003: Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. Journal of Virology 77(16): 8729-8735
Balashov, S.V.; Balashova, N.V.; Boronin, A.M. 1997: Plasmid control of p-toluenesulfonic acid degradation in Comamonas testosteroni BS1310. Mikrobiologiya 66(1): 65-69
Del Solar, G.; Espinosa, M. 2000: Plasmid copy number control: An ever-growing story. Molecular Microbiology 37(3): 492-500
Brandi, L.; Falconi, M.; Ripa, S. 2000: Plasmid curing effect of trovafloxacin. FEMS Microbiology Letters 184(2): 297-302
Ghosh, S.; Mahapatra, N.R.; Ramamurthy, T.; Banerjee, P.C. 2000: Plasmid curing from an acidophilic bacterium of the genus Acidocella. FEMS Microbiology Letters 183(2): 271-274
Hirko, A.C.; Buethe, D.D.; Meyer, E.M.; Hughes, J.A. 2002: Plasmid delivery in the rat brain. Bioscience Reports 22(2): 297-308
Sobecky, P.A. 1999: Plasmid ecology of marine sediment microbial communities. Hydrobiologia 401: 9-18
Hasegawa, K.; Hayashi, T.; Maeda, K.; Onodera, T. 2002: Plasmid encoding interferon-gamma exacerbates reovirus type-2-induced diabetes in DBA/1 suckling mice. Journal of Comparative Pathology 127(2-3): 203-207
Radu, D.L.; Antohi, S.; Bot, A.; Weksler, M.E.; Bona, C. 1999: Plasmid expressing the influenza HA gene protects old mice from lethal challenge with influenza virus. Viral Immunology 12(3): 217-226
Kovac, C.; Clie, L.; Morin, J.; Friedman, F.K.; Robinson, R.; Chung, D.L.; Kanovsky, M.; Flom, J.; Brandt-Rauf, P.W.; Yamaizumi, Z.; Michl, J.; Pincus, M.R. 2001: Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation. Cancer Chemotherapy and Pharmacology 48(1): 9-14
Singh, V.; Singh, V.P.; Chaudhuri, P.; Gupta, P.K.; Sharma, B. 1998: Plasmid fingerprint and homology analysis of 2.5 KB plasmid of Salmonella gallinarum Indian isolates. Indian Veterinary Journal 75(9): 777-780
Andree, C.; Voigt, M.; Wenger, A.; Erichsen, T.; Bittner, K.; Schaefer, D.; Walgenbach, K.J.; Borges, J.; Horch, R.E.; Eriksson, E.; Stark, G.B. 2001: Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Engineering 7(6): 757-766
Simjee, S.; Fraise, A.P.; Gill, M.J. 1999: Plasmid heterogeneity and identification of a Tn5281-like element in clinical isolates of high-level gentamicin-resistant Enterococcus faecium isolated in the UK. Journal of Antimicrobial ChemoTherapy 43(5): 625-635
Chattergoon, M.A.; Maguire, H.H.; Robinson, T.M.; Serrano, E.; Boyer, J.D.; Weiner, D.B. 2002: Plasmid immunization primes unique DTH responses to HIV-1MN envelope epitopes as compared to recombinant protein vaccination. Hybridoma and Hybridomics 21(2): 117-122
Bogdanova, A.I.; Agafonov, M.O.; Ter-Avanesian, M.D. 2000: Plasmid instability in methylotrophic yeast Hansenula polymorpha: the capture of chromosomal DNA fragments by integrative plasmids. Molekuliarnaia Biologiia 34(1): 28-35
Bogdanova, A.I.; Agafonov, M.O.; Ter-Avanesian, M.D. 2000: Plasmid instability in methylotrophic yeast Hansenula polymorpha: the capture of chromosomal DNA fragments by replicative plasmids. Molekuliarnaia Biologiia 34(1): 36-40
Sivov, I.G.; Belyavsky, O.A.; Karataev, G.I. 2000: Plasmid integration in E. coli K12 chromosome caused by Bordetella transposon. Molekulyarnaya Genetika Mikrobiologiya i Virusologiya 2: 33-36
Duann, P.; Sun, M.; Lin, C.T.; Zhang, H.; Liu, L.F. 1999: Plasmid linking number change induced by topoisomerase I-mediated DNA damage. Nucleic Acids Research 27(14): 2905-2911
Avison, M.B.; Higgins, C.S.; von Heldreich, C.J.; Bennett, P.M.; Walsh, T.R. 2001: Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrobial Agents and ChemoTherapy 45(2): 413-419
Fitch, A., J.; Kolesik, P.; Pile, A., J.; Goodman, A., E. 2002: Plasmid maintenance and localisation of Vibrio sp. S141(p519ngfp) cells within monoculture and mixed-species biofilms. Biofouling 18(4): 275-283
Cazorla, D.; Ferrer Miralles, N.; Feliu, J.X.; Carbonell, X.; Villaverde, A. 2001: Plasmid maintenance and recombinant cell fitness explored in bacterial colonies. Biotechnology Letters 23(10): 831-838
Olson, B.; Barkay, T.; Nies, D.; Bellama, J.M.; Colwell, R.R. 1999: Plasmid mediation of mercury volatilization and methylation by estuarine bacteria (Originally published in Developments in Industrial Microbiology, volume 20, pages 275-284). Journal of Industrial Microbiology and Biotechnology 22(4-5): 418-427
Gregorova, D.; Pravcova, M.; Karpiskova, R.; Rychlik, I. 2002: Plasmid pC present in Salmonella enterica serovar Enteritidis PT14b strains encodes a restriction modification system. Fems Microbiology Letters 214(2): 195-198
Pogosyan, G.P.; Lee, K.G.; Nadirova, K.G.; Kaliev, A.B.; Karabaev, M.K. 1999: Plasmid pCL1 and antibacterial activity of Bacillus sp. 62 strain. Molekulyarnaya Genetika Mikrobiologiya i Virusologiya 1999(1): 37-38
Steinmetzer, K.; Kuhn, K.; Behlke, J.; Golbik, R.; Brantl, S. 2002: Plasmid pIP501 encoded transcriptional repressor CopR: Single amino acids involved in dimerization are also important for folding of the monomer. Plasmid 47(3): 201-209
Yoo, J.S.; Shin, Y.H.; Oh, K.S.; Lee, J.K.; Kim, K.S. 1999: Plasmid profile and beta-lactamase type of multidrug-resistant Salmonella typhi isolated from Korea, 1997. Journal of the Korean Society for Microbiology 34(5): 445-452
Paula, M.O.; Gaetti-Jardim Júnior, E.; Avila-Campos, M.J. 2003: Plasmid profile in oral Fusobacterium nucleatum from humans and Cebus apella monkeys. Revista do Instituto de Medicina Tropical de Sao Paulo 45(1): 5-9
Madhavaiah, C.; Verma, S. 2003: Plasmid relaxation induced by copper metalated diglycine conjugates under heterogeneous reaction conditions. Bioorganic and Medicinal Chemistry Letters 13(5): 923-926
Soultanas, P.; Dillingham, M.S.; Papadopoulos, F.; Phillips, S.E.; Thomas, C.D.; Wigley, D.B. 1999: Plasmid replication initiator protein RepD increases the processivity of PcrA DNA helicase. Nucleic Acids Research 27(6): 1421-1428
Khan, S.A. 2000: Plasmid rolling-circle replication: Recent developments. Molecular Microbiology 37(3): 477-484
Poncelet, M.; Cassier-Chauvat, C.; Leschelle, X.; Bottin, H.; Chauvat, F. 1999: Plasmid shuffling manipulation of essential genes in Synechocystis PCC6803: Mutational analysis of the plant-like ferredoxin. Bulletin de l'Institut Oceanographique (Monaco) 1999(SPEC. ISSUE 19): 33-37
Altintas, M.M.; Kirdar, B.; Onsan, Z.I.; Ulgen, K.O. 2001: Plasmid stability in a recombinant S cerevisiae strain secreting a bifunctional fusion protein. Journal of Chemical Technology and Biotechnology 76(6): 612-618
Choi, S.J.; Park, D.H.; Chung, S.I.; Jung, K.H. 2000: Plasmid stability in long-term hG-CSF production using L-arabinose promoter system of Escherichia coli. Journal of Microbiology and Biotechnology 10(3): 321-326
Bilska, V. 2003: Plasmid systems in acetic acid bacteria of genus Acetobacter. Biologia (Bratislava) 58(3): 321-326
Borghese, R.; Zagnoli, A.; Zannoni, D. 2001: Plasmid transfer and susceptibility to antibiotics in the halophilic phototrophs Rhodovibrio salinarum and Rhodothalassium salexigens. FEMS Microbiology Letters 197(1): 117-121
Bhatt, A.; Kieser, H.M.; Melton, R.E.; Kieser, T. 2002: Plasmid transfer from Streptomyces to Mycobacterium smegmatis by spontaneous transformation. Molecular Microbiology 43(1): 135-146
Arrington, J.; Braun, R.P.; Dong, L.; Fuller, D.H.; Macklin, M.D.; Umlauf, S.W.; Wagner, S.J.; Wu, M.S.; Payne, L.G.; Haynes, J.R. 2002: Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines. Journal of Virology 76(9): 4536-4546
Melcher, R.; Grosch, H-Wilhelm.; Hasilik, A. 2002: Plasmid vectors with a 5'-hybrid intron facilitate high-level glycoprotein expression in CHO-cells. Biochimica et Biophysica Acta 1575(1-3): 49-53
Yamaguchi, A.; Katsuyama, K.; Suzuki, K.; Kosaka, K.; Aoki, I.; Yamanaka, S. 2003: Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease. Journal of Molecular Medicine 81(3): 185-193
Boyandin, A.N.; Popova, L.Y.; Pechurkin, N.S. 2000: Plasmid-bearing and plasmidless Bacillus subtilis strains while changing a source of carbon nutrition. Biotekhnologiya 4: 40-44
Hsu, S-Bi.; Tzeng, Y-Huei. 2002: Plasmid-bearing, plasmid-free organisms competing for two complementary nutrients in a chemostat. Mathematical Biosciences 179(2): 183-206
Walther-Rasmussen, J.; Høiby, N. 2002: Plasmid-borne AmpC beta-lactamases. Canadian Journal of Microbiology 48(6): 479-493
Iida, T.; Mukouzaka, Y.; Nakamura, K.; Kudo, T. 2002: Plasmid-borne genes code for an angular dioxygenase involved in dibenzofuran degradation by Terrabacter sp. strain YK3. Applied and Environmental Microbiology 68(8): 3716-3723
Peters, M.; Heinaru, A.; Nurk, A. 2001: Plasmid-encoded catalase KatA, the main catalase of Pseudomonas fluorescens strain Cb36. FEMS Microbiology Letters 200(2): 235-240
Chauhan, A.; Chakraborti, A.K.; Jain, R.K. 2000: Plasmid-encoded degradation of p-nitrophenol and 4-nitrocatechol by Arthrobacter protophormiae. Biochemical and Biophysical Research Communications 270(3): 733-740
Yano, H.; Kuga, A.; Okamoto, R.; Kitasato, H.; Kobayashi, T.; Inoue, M. 2001: Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrobial Agents and ChemoTherapy 45(5): 1343-1348
Frech, G.; Schwarz, S. 1999: Plasmid-encoded tetracycline resistance in Salmonella enterica subsp. enterica serovars choleraesuis and typhimurium: identification of complete and truncated Tn1721 elements. FEMS Microbiology Letters 176(1): 97-103
Navarro-García, F.; Canizalez-Roman, A.; Luna, J.; Sears, C.; Nataro, J.P. 2001: Plasmid-encoded toxin of enteroaggregative Escherichia coli is internalized by epithelial cells. Infection and Immunity 69(2): 1053-1060
Fortineau, N.; Poirel, L.; Nordmann, P. 2001: Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. Journal of Antimicrobial ChemoTherapy 47(2): 207-210
E.Deeb, Bahig, A. 2001: Plasmid-mediated aniline assimilation by Pseudomonas sp. B10. Journal of Microbiology and Biotechnology 11(1): 79-84
Ahmed, B.; Shakoori, A.R. 1997: Plasmid-mediated antibiotic resistance in clinical isolates of Pseudomonas aeruginosa. Punjab University Journal of Zoology 12: 43-48
Yoon, Kyung-Pyo 2002: Plasmid-mediated arsenical and antimonial resistance determinants (ars) of Pseudomonas sp. KM20. Journal of Microbiology and Biotechnology 12(1): 31-38
Girlich, D.; Karim, A.; Spicq, C.; Nordmann, P. 2000: Plasmid-mediated cephalosporinase ACC-1 in clinical isolates of Proteus mirabilis and Escherichia coli. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 19(11): 893-895
Peterson, M.L.; Rotschafer, J.C.; Piddock, L.J.V. 2003: Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis. Journal of Antimicrobial ChemoTherapy 52(3): 481-484
Bozdogan, B.; Leclercq, R.; Lozniewski, A.; Weber, M. 1999: Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032. Antimicrobial Agents and ChemoTherapy 43(8): 2097-2098
Josephy, P.D.; Evans, D.H.; Williamson, V.; Henry, T.; Guengerich, F.P. 1999: Plasmid-mediated expression of the umuDC mutagenesis proteins in an Escherichia coli strain engineered for human cytochrome P450 1A2-catalyzed activation of aromatic amines. Mutation Research 429(2): 199-208
Karim, A.; Poirel, L.; Nagarajan, S.; Nordmann, P. 2001: Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. Fems Microbiology Letters 201(2): 237-241
Galimand, M.; Courvalin, P.; Lambert, T. 2003: Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrobial Agents and ChemoTherapy 47(8): 2565-2571
Stork, M.; Di Lorenzo, M.; Welch, T.J.; Crosa, L.M.; Crosa, J.H. 2002: Plasmid-mediated iron uptake and virulence in Vibrio anguillarum. Plasmid 48(3): 222-228
Wang, M.; Tran, J.H.; Jacoby, G.A.; Zhang, Y.; Wang, F.; Hooper, D.C. 2003: Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrobial Agents and Chemotherapy 47(7): 2242-2248
Su, X.; Hutapea, N.; Tapsall, J.W.; Lind, I. 2003: Plasmid-mediated resistance of Neisseria gonorrhoeae strains isolated from female sex workers in North Sumatra, Indonesia, 1996. Sexually Transmitted Diseases 30(2): 178-182
Kupferwasser, L.I.; Skurray, R.A.; Brown, M.H.; Firth, N.; Yeaman, M.R.; Bayer, A.S. 1999: Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus. Antimicrobial Agents and ChemoTherapy 43(10): 2395-2399
Smith Moland, E.; Hanson, N.D.; Herrera, V.L.; Black, J.A.; Lockhart, T.J.; Hossain, A.; Johnson, J.A.; Goering, R.V.; Thomson, K.S. 2003: Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. Journal of Antimicrobial ChemoTherapy 51(3): 711-714
Epperly, M.W.; Sikora, C.; Defilippi, S.; Bray, J.; Koe, G.; Liggitt, D.; Luketich, J.D.; Greenberger, J.S. 2000: Plasmid/liposome transfer of the human manganese superoxide dismutase transgene prevents ionizing irradiation-induced apoptosis in human esophagus organ explant culture. International Journal of Cancer 90(3): 128-137
Petroni, A.; Corso, A.; Melano, R.; Cacace, Mía.Luisa.; Bru, A.María.; Rossi, A.; Galas, M. 2002: Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina. Antimicrobial Agents and ChemoTherapy 46(5): 1462-1468
Jankowski, S.; Cisowska, A. 1998: Plasmids R577 and R785 decrease the resistance of Escherichia coli K12 strain W1485 to bactericidal action of normal serum. Journal of Applied Genetics 39(3): 211-216
Lin, N.T.; Chang, R.Y.; Lee, S.J.; Tseng, Y.H. 2001: Plasmids carrying cloned fragments of RF DNA from the filamentous phage variant phiLf can be integrated into the host chromosome via site-specific integration and homologous recombination. MGG Molecular Genetics and Genomics 266(3): 425-435
Burger, J.A.; Mendoza, R.B.; Kipps, T.J. 2001: Plasmids encoding granulocyte-macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines. Vaccine 19(15-16): 2181-2189
Tauch, A.; Pühler, A.; Kalinowski, Jörn.; Thierbach, G. 2003: Plasmids in Corynebacterium glutamicum and their molecular classification by comparative genomics. Journal of Biotechnology 104(1-3): 27-40
Nascimento, E.R.; Damassa, A.J.; Yamamoto, R.; Nascimento, M.G.aca F. 1999: Plasmids in Mycoplasma species isolated from goats and sheep and their preliminary typing. Revista de Microbiologia 30(1): 32-36
Deb, J.K.; Nath, N. 1999: Plasmids of corynebacteria. FEMS microbiology letters 175(1): 11-20
Katti, M.K. 2001: Plasmids of mycobacteria. Journal of Medical Microbiology 50(6): 575-576
Cooper, S. 2001: Plasmids pEA29 and pEa34 in Erwinia amylovora are unrelated. Microbiology 147(Part 10): 2632
Shimizu, N.; Miura, Y.; Sakamoto, Y.; Tsutsui, K. 2001: Plasmids with a mammalian replication origin and a matrix attachment region initiate the event similar to gene amplification. Cancer Research 61(19): 6987-6990
Steensma, H.Y.; Ter Linde, J.J. 2001: Plasmids with the Cre-recombinase and the dominant nat marker, suitable for use in prototrophic strains of Saccharomyces cerevisiae and Kluyveromyces lactis. Yeast 18(5): 469-472
Monea, S.; Lehti, K.; Keski-Oja, J.; Mignatti, P. 2002: Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. Journal of Cellular Physiology 192(2): 160-170
McColl, B.K.; Baldwin, M.E.; Roufail, S.; Freeman, C.; Moritz, R.L.; Simpson, R.J.; Alitalo, K.; Stacker, S.A.; Achen, M.G. 2003: Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. Journal of Experimental Medicine 198(6): 863-868
Suelves, M.òn.; López-Alemany, R.; Lluís, F.; Aniorte, G.; Serrano, E.; Parra, M.; Carmeliet, P.; Muñoz-Cánoves, P. 2002: Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood 99(8): 2835-2844
Scollard, P.; Beresford, T.; Needs, E.; Murphy, P.; Kelly, A. 2000: Plasmin activity, beta-lactoglobulin denaturation and proteolysis in high pressure treated milk. International dairy journal 2000(12): 835-841
Lindstedt, L.; Kovanen, P.T. 2000: Plasmin and kallikrein reduce HDL-induced cholesterol efflux from foam cells. Biochemical and Biophysical Research Communications 277(3): 552-557
Van Nostrand, W.E.; Porter, M. 1999: Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry 38(35): 11570-11576
Exley, C.; Korchazhkina, O.V. 2001: Plasmin cleaves Abeta42 in vitro and prevents its aggregation into beta-pleated sheet structures. Neuroreport 12(13): 2967-2970
Murdoch, W.J.; Van Kirk, E.A.; Murdoch, J. 1999: Plasmin cleaves tumor necrosis factor alpha exodomain from sheep follicular endothelium: implication in the ovulatory process. Biology of Reproduction 60(5): 1166-1171
Pryzdial, E.L.; Lavigne, N.; Dupuis, N.; Kessler, G.E. 1999: Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor. Journal of Biological Chemistry 274(13): 8500-8505
Bense, C.A.; Woodhouse, K.A. 1999: Plasmin degradation of fibrin coatings on synthetic polymer substrates. Journal of Biomedical Materials Research 46(3): 305-314
López-Alemany, R.; Suelves, Mònica.; Muñoz-Cánoves, P. 2003: Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis. Thrombosis and Haemostasis 90(4): 724-733
Matsuno, H.; Kozawa, O.; Okada, K.; Ueshima, S.; Matsuo, O.; Uematsu, T. 2002: Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice. Thrombosis and Haemostasis 87(1): 98-104
Pendurthi, U.R.; Ngyuen, M.; Andrade-Gordon, P.; Petersen, L.C.; Rao, L.Vijaya.Mohan. 2002: Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway. Arteriosclerosis Thrombosis and Vascular Biology 22(9): 1421-1426
Ryniers, F.; Stove, C.; Goethals, M.; Brackenier, L.; Noë, V.; Bracke, M.; Vandekerckhove, J.ël.; Mareel, M.; Bruyneel, E. 2002: Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biological Chemistry 383(1): 159-165
Stalboerger, P.G.; Panetta, C.J.; Simari, R.D.; Caplice, N.M. 2001: Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor. Thrombosis and Haemostasis 86(3): 923-928
Lay, A.J.; Jiang, X.-M.; Daly, E.; Sun, L.; Hogg, P.J. 2002: Plasmin reduction by phosphoglycerate kinase is a thiol-independent process. Journal of Biological Chemistry 277(11): 9062-9068
Gopalraj, R.K.; Estus, S. 2003: Plasmin system, Alzheimer's disease and stroke. Proceedings of the Indian National Science Academy Part B Biological Sciences 69(2): 239-250
Pins, G.D.; Collins-Pavao, M.E.; Van De Water, L.; Yarmush, M.L.; Morgan, J.R. 2000: Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices. Journal of Investigative Dermatology 114(4): 647-653
Gonzalez-Gronow, M.; Weber, M.R.; Shearin, T.V.; Gawdi, G.; Pirie-Shepherd, S.R.; Pizzo, S.V. 1998: Plasmin(ogen) carbohydrate chains mediate binding to dipeptidyl peptidase IV (CD 26) in rheumatoid arthritis human synovial fibroblasts. Fibrinolysis and Proteolysis 12(6): 366-374